<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-id journal-id-type="hwp">nar</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/nar/gkn413</article-id><article-id pub-id-type="publisher-id">gkn413</article-id><article-id pub-id-type="pmid">18596081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Gene Regulation, Chromatin and Epigenetics</subject></subj-group></article-categories><title-group><article-title>Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spatuzza</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schiavone</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Di Salle</surname><given-names>Emanuela</given-names></name><xref ref-type="aff" rid="AFF1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Janda</surname><given-names>Elzbieta</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sardiello</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="AFF1"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fiume</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fierro</surname><given-names>Olga</given-names></name><xref ref-type="aff" rid="AFF1"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Simonetta</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="AFF1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Argiriou</surname><given-names>Notis</given-names></name><xref ref-type="aff" rid="AFF1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Faraonio</surname><given-names>Raffaella</given-names></name><xref ref-type="aff" rid="AFF1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Capparelli</surname><given-names>Rosanna</given-names></name><xref ref-type="aff" rid="AFF1"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Quinto</surname><given-names>Ileana</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="COR1">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Scala</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib></contrib-group><aff id="AFF1"><sup>1</sup>Department of Experimental and Clinical Medicine, University of Catanzaro &#x02018;Magna Graecia&#x02019;, 88100 Catanzaro, <sup>2</sup>Department of Biochemistry and Medical Biotechnology, University of Naples &#x02018;Federico II&#x02019;, <sup>3</sup>Telethon Institute of Genetics and Medicine, 80131 Naples, <sup>4</sup>Institute of Food Sciences, CNR, Avellino and <sup>5</sup>Department of Biotechnological Sciences, University of Naples &#x02018;Federico II&#x02019;, Naples, Italy</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed. <phone>+39 0961 3694058</phone> (office) <fax>+39 0961 3694090</fax><email>quinto@unicz.it</email> Correspondence may also be addressed to Giuseppe Scala. <phone>+39 0961 3694059</phone> (office) <fax>+39 0961 3694090</fax><email>scala@unicz.it</email></corresp><fn><p>Present address: Notis Argiriou, Center for Research and Technology-Hellas, 570 01 Thermi&#x02013;Thessaloniki, Greece</p></fn><fn><p>The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors</p></fn></author-notes><!--For NAR: both ppub and collection dates generated for PMC processing 1/27/05 beck--><pub-date pub-type="collection"><month>8</month><year>2008</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2008</year></pub-date><pub-date pub-type="epub"><month>8</month><year>2008</year></pub-date><volume>36</volume><issue>13</issue><fpage>4402</fpage><lpage>4416</lpage><history><date date-type="received"><day>9</day><month>1</month><year>2008</year></date><date date-type="rev-recd"><day>12</day><month>6</month><year>2008</year></date><date date-type="accepted"><day>13</day><month>6</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; 2008 The Author(s)</copyright-statement><copyright-year>2008</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Bruton's tyrosine kinase (Btk) is required for B-cell development. Btk deficiency causes X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. Btk lacks a negative regulatory domain and may rely on cytoplasmic proteins to regulate its activity. Consistently, we identified an inhibitor of Btk, IBtk, which binds to the PH domain of Btk and down-regulates the Btk kinase activity. IBtk is an evolutionary conserved protein encoded by a single genomic sequence at 6q14.1 cytogenetic location, a region of recurrent chromosomal aberrations in lymphoproliferative disorders; however, the physical and functional organization of <italic>IBTK</italic> is unknown. Here, we report that the human <italic>IBTK</italic> locus includes three distinct mRNAs arising from complete intron splicing, an additional polyadenylation signal and a second transcription start site that utilizes a specific ATG for protein translation. By northern blot, 5&#x02032;RACE and 3&#x02032;RACE we identified three <italic>IBTK&#x003b1;</italic>, <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic> mRNAs, whose transcription is driven by two distinct promoter regions; the corresponding IBtk proteins were detected in human cells and mouse tissues by specific antibodies. These results provide the first characterization of the human <italic>IBTK</italic> locus and may assist in understanding the <italic>in vivo</italic> function of IBtk.</p></abstract></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Bruton's tyrosine kinase (Btk) is a member of the Tec family of nonreceptor protein tyrosine kinases that includes TECI and TECII, BMX, TXK, ITK and Dsrc 28C (<xref ref-type="bibr" rid="B1 B2 B3">1&#x02013;3</xref>). These kinases are characterized by the Src homology-1 (SH1) tyrosine kinase domain and by additional SH2 and SH3 regions, which function as protein&#x02013;protein interaction sites (<xref ref-type="bibr" rid="B4">4</xref>). The structure of Btk includes a unique NH<sub>2</sub>-terminal region containing a Plecktrin homology (PH) domain that regulates the Btk kinase activity; accordingly, mutations in several <italic>BTK</italic> domains lead to a severe X-linked agammaglobulinemia (XLA) in humans (<xref ref-type="bibr" rid="B5">5</xref>). Moreover, a specific mutation of the conserved Arg<sup>28</sup> residue in the Btk-PH domain leads to a severe X-linked immunodeficiency (Xid) phenotype in mice (<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>). Individuals with XLA show a severe immunodeficiency as a consequence of a significant reduction of mature B cells and immunoglobulin levels (<xref ref-type="bibr" rid="B4">4</xref>). Accordingly, mice with Xid carry mutations in the <italic>BTK</italic> gene and show a decreased number of mature B cells that fail to proliferate properly upon B-cell receptor (BCR) cross-linking (<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B8">8</xref>). Several signal pathways are induced upon Btk kinase activation. Evidence from Btk-deficient B cells (DT40) (<xref ref-type="bibr" rid="B9">9</xref>) indicates that Btk is required for a proper tyrosine phosphorylation of phospholipase C-gamma (PLC-&#x003b3;), which in turn leads to inositol-3,4,5-triphosphate (IP<sub>3</sub>), a major mediator of [Ca<sup>2+</sup>]i mobilization, and to diacylglycerol, an activator of protein kinase C (PKC) (<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>). These pathways activate specific transcription factors, including nuclear factor-kappaB (NF-&#x003ba;B) and BAP135-TFII-I (<xref ref-type="bibr" rid="B12 B13 B14 B15">12&#x02013;15</xref>), which regulate the gene transcription program required for B-cell survival and cell-cycle progression. Btk activation is also induced upon a direct interaction between the Btk-PH domain and G-protein subunits (<xref ref-type="bibr" rid="B16">16</xref>). Further, Btk regulates some intracellular apoptotic pathways and plays a role in cell-cycle regulation and tumorigenesis of B cells (<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>). Indeed, Btk is a major regulator of B-cell apoptosis and cooperates with tumor suppressor genes, including SLP-65 (<xref ref-type="bibr" rid="B17 B18 B19 B20">17&#x02013;20</xref>).</p><p>Little is known of the regulation of Btk function. Unlike Src proteins, Btk lacks a negative regulatory domain and may rely on cytoplasmic Btk-binding proteins to regulate its kinase activity by <italic>trans</italic>-inhibitor mechanisms. Consistent with this possibility, we have studied a newly identified inhibitor of Btk (IBtk), which binds specifically to the PH domain of Btk and down-regulates its kinase activity. IBtk was isolated by screening a human B-lymphoblastoid cDNA library in the yeast two-hybrid system by using specific domains of Btk as a bait (<xref ref-type="bibr" rid="B21">21</xref>). The results were as follows: (i) IBtk is an evolutionary conserved protein encoded by a single genomic sequence at a 6q14.1 cytogenetic location, a region of recurrent chromosomal aberrations in lymphoproliferative disorders (<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>); (ii) IBtk specifically associates with Btk, as demonstrated by both <italic>in vitro</italic> and <italic>in vivo</italic> protein&#x02013;protein interaction assays. Confocal microscopy revealed a sub-membrane co-localization of IBtk and Btk and (iii) upon binding to Btk, IBtk down-regulates the Btk kinase activity, as shown by using as a substrate both endogenous Btk and a peptide corresponding to the Btk-SH3 domain that includes the Tyr223 autophosphorylation site (<xref ref-type="bibr" rid="B21">21</xref>). Btk is essential for B-cell survival and cell-cycle progression following BCR triggering (<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>). In this setting, Btk regulates [Ca<sup>2+</sup>]i entry and mobilization from intracellular stores that ultimately lead to the activation of transcription factors, including NF-&#x003ba;B (<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>). Consistent with the above results, IBtk inhibited the [Ca<sup>2+</sup>]i fluxes in Indo-1-loaded DT40 cells upon anti-IgM stimulation and the NF-&#x003ba;B-driven transcription was observed upon anti-IgM stimulation; IBtk expression resulted in a dose-dependent inhibition of this activity (<xref ref-type="bibr" rid="B21">21</xref>). These results indicate that IBtk plays a crucial role in the <italic>in vivo</italic> regulation of Btk-mediated B-cell function; however, no reports have addressed the physical and functional characterization of the <italic>IBTK</italic> locus. In this study, we report a detailed description of the human <italic>IBTK</italic> locus and provide evidence for a complex genomic organization that gives rise to three distinct mRNAs, <italic>IBTK&#x003b1;</italic>, <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic>, which are translated in the corresponding proteins IBtk&#x003b1;, IBtk&#x003b2; and IBtk&#x003b3;.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Genomic analysis of the <italic>IBTK</italic> genomic locus</title><p><italic>Canis familiaris</italic>, <italic>Bos taurus</italic>, <italic>Mus musculus</italic>, <italic>Gallus gallus</italic>, <italic>Xenopus tropicalis</italic>, <italic>Fugu rubripes</italic> and <italic>Tetraodon nigroviridis</italic> genomic sequences were searched for <italic>IBTK</italic> homologous genes with TBLASTN (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nih.gov/BLAST/">http://www.ncbi.nih.gov/BLAST/</ext-link>) and BLAT (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>) using the amino acid sequence of human IBtk&#x003b1; as a query. The retrieved genomic segments were aligned to the available cDNA/EST sequences to infer the gene architecture. For genes that lacked a transcript counterpart, a careful manual examination of candidate genomic sequences was performed, by looking for splicing donor and acceptor signals to define the gene structure (<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>).</p></sec><sec><title>Evolutionary analysis of <italic>IBTK</italic> gene</title><p>Amino acid sequence alignments were performed with MULTIALIN (<xref ref-type="bibr" rid="B28">28</xref>). Local evolution rates over the amino acid sequences of IBtk&#x003b1; proteins were estimated with the evolution&#x02013;structure&#x02013;function method (<xref ref-type="bibr" rid="B29">29</xref>). This analysis requires a preliminary reconstruction of the evolutionary relationships among all analyzed peptides. We built the phylogenetic tree of investigated IBtk&#x003b1; proteins using PHYLO-WIN (<xref ref-type="bibr" rid="B30">30</xref>) and by holding its branching pattern constant, we calculated the number of substitution per site in each 15-residue wide window over the entire amino acid alignment with CODEML (<xref ref-type="bibr" rid="B31">31</xref>). Finally, rate values were calculated by dividing the number of substitutions per site in each window by the average of all windows (providing the &#x02018;relative rate&#x02019;). The final values were then computed by smoothing the relative rates with a seven-position moving window arithmetic average. The evolutionary profile was plotted as a function of alignment position in a 2D array. A ranked list of local minima, which define the evolutionarily constrained regions (ECRs), was obtained by scanning the array from the bottom (minimum) to top (maximum). Pair-wise sequence identities were calculated at the European Bioinformatics Institute website (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/emboss/align/">http://www.ebi.ac.uk/emboss/align/</ext-link>). Synonymous and nonsynonymous substitution ratios were calculated at the SNAP website [<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov">http://www.hiv.lanl.gov</ext-link>; (<xref ref-type="bibr" rid="B32">32</xref>)]. Analysis of canonical and noncanonical splice sites in mammalian genomes was performed as reported (<xref ref-type="bibr" rid="B33">33</xref>) by mining GenBank, EMBL (<xref ref-type="bibr" rid="B34">34</xref>), and UCSC Genome Browser Database (<xref ref-type="bibr" rid="B35">35</xref>).</p></sec><sec><title><italic>IBTK</italic> intron 24 amplification from <italic>Pongo pygmaeus</italic> and <italic>Pan troglodytes</italic></title><p>Genomic DNA of <italic>P. pygmaeus</italic> and <italic>P. troglodytes</italic> were used to test the evolutionary conservation of <italic>IBTK</italic> intron 24 among the primate nonhuman species. Genomic DNA (250 ng) was used to perform a PCR reaction. Specific primers were used to amplify the <italic>IBTK</italic> intron 24: primer ex24f (5&#x02032;-GTC AGC CCT CCT GTT GTG GAT-3&#x02032;) and primer ex25r (5&#x02032;-TGC ATT CAC TGG TTT GGG GGC-3&#x02032;). The amplified DNA was eluted from the agarose gel and analyzed by sequencing with an ABI PRISM DNA sequencing system (Applied Biosystems, Foster City, CA, USA).</p></sec><sec><title>Cell cultures</title><p>MC3 and DeFew B cells (<xref ref-type="bibr" rid="B36">36</xref>), NB4 and Jurkat T cells were grown in RPMI 1640 (Cambrex, East Rutherford, NJ, USA) supplemented with 10% fetal bovine serum (FBS) (Cambrex), 2mM <sc>l</sc>-glutamine, 100 U/ml of penicillin and 100 U/ml of streptomycin (Biowhittaker, Walkersville, MD, USA). 293T (human embryonic kidney cells) and HeLa (human epithelial cells from cervical carcinoma) cells were grown in DMEM (Cambrex) containing 10% FBS, 2mM <sc>l</sc>-glutamine, 100 U/ml of penicillin and 100 U/ml of streptomycin. Cell lines were incubated at 37&#x000b0;C with 100% humidity in 5% CO<sub>2</sub>. Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats by using Ficoll Paque gradient (GE Healthcare Europe, Munich, Germany). Briefly, donor blood was diluted 1:10 in PBS 1&#x000d7; and stratified on Ficoll solution with a 3:1 v/v ratio. After a 30 min centrifugation at 2200 r.p.m., PBMC were recovered and re-suspended in RPMI-1640 medium supplemented with 10% FCS.</p></sec><sec><title>RNA extraction and RT&#x02013;PCR</title><p>Total RNA was extracted by using the TRIzol reagent (Invitrogen, Karlsruhe, Germany). PolyA mRNA was isolated by using Oligotex mRNA Mini Kit (Qiagen, Hilden, Germany). MC3 total RNA (200 ng) and polyA mRNA (20 ng) was used to synthesize three double strand cDNAs with SuperScript One-Step RT&#x02013;PCR with Platinum Taq (Invitrogen). Briefly, the RT&#x02013;PCR reactions were performed in a single step using three pairs of <italic>IBtk&#x003b1;</italic>, <italic>IBtk&#x003b2;</italic>, <italic>IBtk&#x003b3;</italic> specific primers: (i) ex24f (5&#x02032;-GTC AGC CCT CCT GTT GTG GAT-3&#x02032;) coupled with I24r (5&#x02032;-TGG ATC AAA ATG CTC ACA AGT T-3&#x02032;) amplified a cDNA fragment of <italic>IBtk&#x003b2;</italic>; (ii) ex24f (5&#x02032;-GTC AGC CCT CCT GTT GTG GAT-3&#x02032;) coupled with ex25r (5&#x02032;-TGC ATT CAC TGG TTT GGG GGC-3&#x02032;) amplified a cDNA fragment of <italic>IBtk&#x003b1;</italic> and (iii) I24f (5&#x02032;-TGG GCA ATT TAG CCT CCA TA-3&#x02032;) coupled with ex25r (5&#x02032;-TGC ATT CAC TGG TTT GGG GGC-3&#x02032;) amplified a cDNA fragment of <italic>IBtk&#x003b3;</italic>. The cDNA fragments were analyzed by electrophoresis on 1.5% agarose gel and sequenced.</p></sec><sec><title>Northern blot</title><p>MC3, Jurkat and HeLa polyA mRNA (1 &#x003bc;g) was fractionated by electrophoresis on a formaldehyde&#x02013;1% agarose gel and transferred on Hybond N<sup>+</sup> nylon strips (GE Healthcare). Filters were alternatively hybridized with two <sup>32</sup>P-labeled human <italic>IBTK</italic> fragments: ex12 probe and int24 probe. A <sup>32</sup>[P]-labeled human GAPDH fragment was used as equal loading control probe. The following primers were used to generate DNA amplicons as probes: for <italic>IBTK</italic> (&#x003b1; and &#x003b2;) ex12 probe: ex12f 5&#x02032;-GCA ATA GAC TCT TCC CTG CAC-3&#x02032; and ex12r 5&#x02032;-GGC AGA AGA GCA AAC CTA AAT-3&#x02032;; for <italic>IBTK&#x003b3;</italic> int24 probe: I24/f 5&#x02032;-TGG GCA ATT TAG CCT CCA TA-3&#x02032; and I24r 5&#x02032;-AAC TTG TGA GCA TTT TGA TCC A-3&#x02032;; for <italic>GAPDH</italic> probe: GAPDHf 5&#x02032;-GAA GGT GAA GGT CGG AGTC-3&#x02032;, GAPDHr: 5&#x02032;-GAA GAT GGT GAT GGG ATT TC-3&#x02032;.</p></sec><sec><title>5&#x02032;-rapid amplification of cDNA end</title><p>PolyA mRNA was isolated from MC3 cells by using the TRIzol reagent method (Invitrogen) and Oligotex mRNA mini kit (Qiagen). Two 5&#x02032;-rapid amplification of cDNA end (5&#x02032;RACE) reactions were performed by using 5&#x02032;RACE System 2.0 kit (Invitrogen) to find two transcription start sites (TSS): one for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic>, and a distinct one for <italic>IBTK&#x003b3;</italic>. The 5&#x02032;RACE was performed in three reactions: one RT&#x02013;PCR to synthesize the first strand cDNA followed by two nested PCR. Briefly, the first strand cDNAs were synthesized from 1 &#x003bc;g of mRNA by SuperScriptII RNA polymerase reaction using the specific primers GSP1R (5&#x02032;-GAG TGA GGA GGG GAA CT-3&#x02032;) for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic>, and GSP6R (5&#x02032;-GAG TCA AGT TTC TGG GAT GTA ATA CTG-3&#x02032;) for <italic>IBTK&#x003b3;</italic>. After adding an oligo-dC tail to the 3&#x02032;-ends of cDNAs, two nested PCR rounds were performed using more internal primers. The first nested PCR round was performed with GSP2R primer (5&#x02032;-GGT GAC CAG TCG CTA GAT GAA A-3&#x02032;), specific for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic> and GSP5R primer (5&#x02032;-GAG TCA AGT TTC TGG GAT GTA ATA CTG-3&#x02032;) specific for the <italic>IBTK&#x003b3;</italic>, coupled with an Abridged Anchor Primer (AAP) (5&#x02032;-GGC CAC GCG TCG ACT AGT ACG GGI IGG GII GGG IIG-3&#x02032;) containing oligo-dI-dG at the 3&#x02032;-end of the primer. The second nested PCR round was performed with GSP3R primer (5&#x02032;-GGT GGA TTC CGC AGG GTC CAC ATA-3&#x02032;) specific for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic> and GSP4R primer (5&#x02032;-GGA GGC TAA ATT GCC CAG AAA AGG-3&#x02032;) specific for <italic>IBTK&#x003b3;</italic>. The resulting DNA fragments were eluted from agarose gel and were analyzed by sequencing with an ABI PRISM DNA sequencing system (Applied Biosystems).</p></sec><sec><title>3&#x02032;-rapid amplification of cDNA end</title><p>To map the 3&#x02032;-end of the three transcripts <italic>IBTK&#x003b1;</italic>, <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic>, we performed two 3&#x02032;-rapid amplification of cDNA end (3&#x02032;RACE) reactions. The first strand cDNAs were synthesized from 1 &#x003bc;g of MC3 PolyA mRNA by reverse transcriptase using 3&#x02032;RACE System (Invitrogen) with a 3&#x02032;RACE primer displaying an adaptor sequence at the 5&#x02032;-end of the oligo-dT (5&#x02032;-GGC CAC GCG TCG ACT AGT ACT TTT TTT TTT TTT TTT T-3&#x02032;). Three PCR-rounds were performed: in the first one, cDNA was amplified with the adaptor primer and specific primers, GSP4L (5&#x02032;-CCT TTT CTG GGC AAT TTA GCC TCC ATA-3&#x02032;) for <italic>IBTK&#x003b2;</italic> and GSP7L (5&#x02032;-GCC TGG GAG ACA CAT AAG CAA T-3&#x02032;) for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b3;</italic>. The first nested PCR round was performed by using adaptor primer and other more internal specific primers, GSP5L (5&#x02032;-CAG TAT TAC ATC CCA GAA ACT TGA CTC-3&#x02032;) for <italic>IBTK&#x003b2;</italic> and GSP8L (5&#x02032;-GAA GGT AAG CCT GGG AGA CAC ATA -3&#x02032;) for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b3;</italic>. The last nested PCR round was performed by using adaptor primer and specific primers GSP6L (5&#x02032;-GTG ATA TGT TGG AGG GCT CAT A-3&#x02032;) for <italic>IBTK&#x003b2;</italic> and GSP9L (5&#x02032;-CAG AAG TTC TCT GAA CCT CAA TTG T -3&#x02032;) for <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b3;</italic>. Following electrophoresis in 2% agarose gel, the final PCR product was eluted (QIAEXII Gel Extraction kit&#x02014;Qiagen). DNA sequence was determined with an ABI PRISM DNA sequencing system (Applied Biosystems).</p></sec><sec><title><italic>IBTK</italic>-luciferase reporter assays</title><p>Distinct fragments of <italic>IBtk&#x003b1;</italic>, <italic>IBtk&#x003b2;</italic> and <italic>IBtk&#x003b3;</italic> promoter regions were obtained by PCR amplification of human genomic DNA and inserted in pGL3-basic vector (Promega, Madison, WI, USA) after digestion with KpnI and BglII. For <italic>IBtk&#x003b1;</italic> and <italic>IBtk&#x003b2;</italic> promoter, we analyzed four fragments designed as: &#x02212;754/+22, &#x02212;159/+22, &#x02212;82/+22 and &#x02212;67/+22. The following forward primers were used: for &#x02212;754/+22, 5&#x02032;-GGG GTA CCA GGC ATT CAG CAG CAG TGT G-3&#x02032;; for &#x02212;159/+22, 5&#x02032;-GGG GTA CCC GGC GAG GTC AAG TTC CTT T-3&#x02032;; for &#x02212;82/+22, 5&#x02032;-GGG GTA CCG CAC CAG CCA ATC ATC AAG AG-3&#x02032;; for &#x02212;67/+22, 5&#x02032;-GGG GTA CCC AAG AGA CAT ACA GGA GCC C-3&#x02032;. The reverse primer was: 5&#x02032;-GAA GAT CTC GGG AAC GGG GAT GTA GA-3&#x02032;. In the case of the <italic>IBTK&#x003b3;</italic> promoter, we analyzed two fragments designed as: &#x02212;691/+5 and &#x02212;155/+5. The following forward primers were used: for &#x02212;691/+5, 5&#x02032;-GGG GTA CCG GCT GTA GTG CAG TGG TAT GAT-3&#x02032;; for &#x02212;155/+5, 5&#x02032;-GGG GTA CCT CCT GTC AGC CCT CCT GTT G-3&#x02032;. The reverse primer was: 5&#x02032;-GAA GAT CTG TCT GTC CAA TTC TTA GGG CAG AA-3&#x02032;.</p><p>Cell transfection and luciferase reporter assays were performed as follows: 293T cells (3 &#x000d7; 10<sup>5</sup>/well) were seeded in 6-well tissue culture plates 24 h before transfection. Cells were transfected by using the calcium phosphate method (Invitrogen) according to the manufacturer's instruction. The luciferase gene expression driven by an empty pGL3 Basic vector was used as negative control. To normalize the transfection efficiency, cells were co-transfected with pCMV &#x003b2;-gal vector (0.2 &#x003bc;g), which expresses the <italic>&#x003b2;-galactosidase</italic> gene from the cytomegalovirus promoter (Clontech, Mountain View, CA, USA). Each sample was transfected with <italic>luc</italic> reporter plasmids (0.5 &#x003bc;g). Twenty-four hours posttransfection, cells were washed twice with PBS and harvested. Cell lysates and luciferase reporter assay were performed using Dual Light System (Applied Biosystem). Results were normalized according to the luciferase to &#x003b2;-galactosidase activity ratio and normalized for the protein concentration. A minimum of four independent experiments were performed; arithmetic mean and SEM values were used for graphic representation.</p></sec><sec><title>Real-time PCR analysis</title><p>Real-time quantitative RT&#x02013;PCR on <italic>IBTK</italic> cDNAs was carried out with the iQ<sup>TM</sup> SYBR&#x000ae; Green Super mix using the iCycler iQ real-time detection system (Bio-Rad, Munich, Germany) with the following conditions: 95&#x000b0;C, 1 min; (94&#x000b0;C, 10 s; 60&#x000b0;C, 30 s) &#x000d7; 40. The oligonucleotides for PCR were RT24f (5&#x02032;-CCTCCTGTTGTGGATCTCAGAACTAT-3&#x02032;) and RT25r (5&#x02032;-GAGAAAGTTTAACTCCATGAGAAAC-3&#x02032;) for <italic>IBTK&#x003b1;</italic>; RT24f and RT24Ar (5&#x02032;-AGGGCAGAAATACAACATGAAATG-3&#x02032;) for <italic>IBTK&#x003b2;</italic>; RT24If (5&#x02032;-CCAGTAACCTTTATTAAGCAGAAATTAATGTTA-3&#x02032;) and RT25rII (5&#x02032;-CATGCATTCACTGGTTTGGGGGC-3&#x02032;) for <italic>IBTK&#x003b3;</italic>. The reactions were performed in triplicate using as templates cDNA preparations from 15 different human tissues [Human multiple tissue cDNA (MTC) Panel I and II, Clontech] and the following cell types: HeLa, DeFew, Jurkat cell lines and primary PBMC. Expression levels were calculated relative to <italic>GAPDH</italic> mRNA levels as endogenous control. Relative expression was calculated as 2<sup>(Ct test gene &#x02013; Ct GAPDH)</sup> (<xref ref-type="bibr" rid="B37">37</xref>). Oligo efficiencies were tested using as a template serial dilutions of &#x003b1;, &#x003b2; and &#x003b3; amplicons cloned in pTA cloning vector plasmid (Invitrogen).</p></sec><sec><title>IBtk antibodies production and western blot analysis</title><p>Antibody against IBtk&#x003b1; and IBtk&#x003b2; was raised in chicken by taking advantage of a unique peptide sequence, NFHEDDNQKS, not shared by the <italic>G. gallus</italic> (shown in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S1</ext-link>). Two chickens were immunized with 31B peptide NFHEDDNQKSC (aa 672&#x02013;681 of IBtk&#x003b1; and IBtk&#x003b2;) conjugated with KLH (keyhole limpet hemocyanin) (Gallus Immunotech Inc., Fergus, ON, Canada). One primary immunization (0.75 mg of 31B peptide in Freund's complete adjuvant) and three boostings (0.25 mg of 31B peptide in Freund's incomplete adjuvant) were performed. IgY anti-31B specific were purified by affinity chromatography using 31B-conjugated sepharose (NHS-activated Sepharose 4 Fast Flow, GE Healthcare). In addition, to overcome the constraint of amino acid sequence homology of IBtk over multiple species, including <italic>M. musculus</italic>, polyclonal antibodies against IBtk&#x003b1; and IBtk&#x003b3; were raised in <italic>Ibtk</italic><sup>&#x02212;/&#x02212;</sup> mouse by GST-IBtk&#x003b3; immunization. The development of the <italic>Ibtk</italic><sup>&#x02212;/&#x02212;</sup> mouse will be reported elsewhere. The cDNA fragment corresponding to the full-length IBtk&#x003b3; was generated by RT&#x02013;PCR (Invitrogen) of total RNA isolated from MC3 cells, by using the following primers: 5&#x02032;-CGGAATTCCGGTGGTGGTGGTCCGTTAATTGATATAATTTCTAGCAAAATGATTTCTC-3&#x02032; and 5&#x02032;-CCGCTCGAGGCATCTCAACTCCACAGTG-3&#x02032;. The fragment was inserted in pGEX-4T-3 vector (GE Healthcare) at EcoRI and XhoI sites. GST-IBtk&#x003b3; protein was expressed in BL21 host <italic>Escherichia coli</italic> strain. Insoluble GST-IBtk&#x003b3; was recovered from inclusion bodies by using a denaturing solution (8 M urea, 1% Triton X-100, 5 mM DTT) and purified by gel electrophoresis. Mice were primed with 0.2 mg of GST-IBtk&#x003b3; in Freund's complete adjuvant and boosted with three distinct inoculations of GST-IBtk&#x003b3; (0.1 mg) in incomplete Freund's adjuvant. The titers and specificity of anti-IBtk sera were assessed by ELISA. Endogenous IBtk proteins were detected by western blot as follows: mouse (adult C57BL) and human cells were lyzed in RIPA buffer (50 mM Tris&#x02013;HCl pH 7.4, 1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF and protease inhibitors) and subjected to SDS&#x02013;polyacrylamide 8% or 12% gel electrophoresis followed by transfer to a PVDF membrane (GE Healthcare). IBtk&#x003b1; and IBtk&#x003b2; were detected by using the chicken 31B IgY antibody (10 &#x003bc;g/ml) followed by incubation with a anti-chicken-HRP (Gallus Immunotech Inc.). The binding specificity was assessed by preincubating the primary antibody with the 31B peptide (molar ratio IgY/peptide = 1/1000). IBtk&#x003b1; and IBtk&#x003b3; proteins were detected by using an anti-GST-IBtk&#x003b3; serum (dilution 1:500) followed by incubation with anti-mouse-HRP (GE Healthcare). In the case of DeFew cells, the primary antibody was preincubated with either GST (60 nmoles/ml), or GST-IBtk&#x003b3; (60 nmoles/ml). Cellular &#x003b3;-tubulin was detected by immunoblotting with a specific antibody (Sigma-Aldrich, Buchs, SG, Switzerland) followed by an anti-mouse-HRP (GE Healthcare). Antibody&#x02013;protein bindings were visualized by enhanced chemiluminescence (ECL and ECL Plus, GE Healthcare).</p></sec><sec><title>Regulation of <italic>IBTK</italic> transcripts by an <italic>IBTK</italic>-specific shRNA</title><p>HEK 293 LinX packaging cell line (Open Biosystem, Huntsville, AL, USA) was cultured in DMEM containing 10% FBS, 2 mM <sc>l</sc>-glutamine, 100 U/ml of penicillin and 100 U/ml of streptomycin 100 &#x003bc;g/ml of hygromycin. Jurkat cells expressing either a stably control shRNA, or the <italic>IBTK</italic>-shRNA SH2407H3, were cultured in RPMI-1640 supplemented with 10% FBS, 2 mM <sc>l</sc>-glutamine, 100 U/ml of penicillin, 100 U/ml of streptomycin and 1 &#x003bc;g/ml puromycin. HEK 293 LinX packaging cell line (Open Biosystem) was transfected with 10 &#x003bc;g of either empty plasmid, or with a plasmid expressing the IBTK-specific shRNA clone SH2407H3 (Open Biosystem). Forty-eight hours posttransfection, the cell supernatants were collected and filtered with 0.45 &#x003bc;m. Jurkat cells (4 &#x000d7; 10<sup>6</sup>) were infected with 1 ml of filtered supernatant by spinoculation (<xref ref-type="bibr" rid="B38">38</xref>); 24 h later, the culture medium was supplemented with 1 &#x003bc;g/ml puromycin. The sequence of IBTK shRNA SH2407H3 was 5&#x02032;-TGCTGTTGACAGTGAGCGACGGGATTTCTTACTAGAAGAATAGTGAAGCCACAGATGTA<bold>TTCTTCTAGT AAGAAATCCCGG</bold>TGCCTACTGCCTCGGA-3&#x02032; with annealing sequence to exon 26 of the <italic>IBTK&#x003b1;</italic> transcript (nucleotide +4162&#x02013;4183; shown in bold). The shRNA sequence is also specific for the <italic>IBTK&#x003b3;</italic> transcript (nucleotide +692&#x02013;713); shown in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S6B</ext-link>.</p></sec><sec><title>Protein&#x02013;protein interaction</title><p>PBMC extracts were performed in RIPA-Buffer. Antibodies (5 &#x003bc;g) were preincubated with (20 &#x003bc;l) of protein G-Agarose (GammaBind Plus Sepharose GE Healthcare) in 200 &#x003bc;l of immunoprecipitation RIPA buffer overnight at 4&#x000b0;C on a rocking platform. The cell extracts were precleared on protein G. The protein G-agarose-coupled antibodies were incubated with cell extract (1 mg) in 500 &#x003bc;l of immunoprecipitation RIPA buffer overnight at 4&#x000b0;C on a rocking platform. The immunocomplexes were collected by centrifugation at 2200 r.p.m. for 3 min at 4&#x000b0;C, washed five times in 900 &#x003bc;l of RIPA buffer and resuspended in SDS gel loading buffer. The proteins were separated on either 8% or 12% SDS&#x02013;polyacrylamide gel, transferred to PVDF membrane and analyzed by immunoblotting. IBtk&#x003b1; and IBtk&#x003b2; were detected by using the chicken 31B IgY antibody (10 &#x003bc;g/ml) followed by incubation with a anti-chicken-HRP (Gallus Immunotech Inc.). IBtk&#x003b3; was detected by using an anti-GST-IBtk&#x003b3; serum (dilution 1:500) followed by incubation with anti-mouse-HRP (GE Healthcare). The following antibodies were used for immunoprecipitation and for control immunoblotting: anti-Btk (E-9), anti-Emt (Itk) (2F12), anti-PLC&#x003b3;1 (E-12) and anti-Akt1 (B-1), normal mouse IgG1 (Santa Cruz, Santa Cruz, CA, USA).</p></sec><sec><title>Confocal analysis</title><p>Intracellular localization of IBtk isoforms in B lymphoma cells (DeFew) was assessed by confocal microscopy as previously described (<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B39">39</xref>). The cDNA fragments corresponding to the full-length IBtk&#x003b1;, IBtk&#x003b2; and IBtk&#x003b3; were generated by RT&#x02013;PCR (Invitrogen) of total RNA isolated from MC3 cells, by using the following primers: for IBtk&#x003b1; 5&#x02032;-CCGAAGCTTCCTGACTGCACATCAAAGTGTCGATC-3&#x02032; and 5&#x02032;-CGGGATCCCTAGCATCCATGCTTATTCAACATAGG-3&#x02032;, for IBtk&#x003b2; 5&#x02032;-CCGAAGCTTCCTGACTGCACATCAAAGTGTCGATC-3&#x02032; and 5&#x02032;-CGGGATCCGAGTCAAGTTTCTGGGATGTAATACTG-3&#x02032;, for IBtk&#x003b3; 5&#x02032;-TTAATTGATATAATTTCTAGCAAAATGATTTCTC-3&#x02032; and 5&#x02032;-CGGGATCCCTAGCATCCATGCTTATTCAACATAGG-3&#x02032;. The fragment was inserted in p3XFLAG-CMV-7.1 vector (Sigma) at HindIII and BamH1 sites. DeFew cells were transiently transfected with plasmids coding for the three isoforms of IBtk (&#x003b1;, &#x003b2; and &#x003b3;) fused to FLAG tag. Twenty-four hours later the cells were fixed and stained with FITC-conjugated anti-FLAG Ab (Green) and anti-Btk Ab, followed by Alexa-568 secondary Ab (Red, Molecular Probes, Eugene, OR, USA) and DAPI to detect nuclear DNA. DeFew B cells were seeded on poly-<sc>l</sc>-lysine-treated glass coverslips, fixed and permeabilized using Cytofix/CytoPerm kit (BD Biosciences Pharmingen, San Diego, CA, USA). Coverslips were mounted on glass slides by using ProLong Antifade Kit (P7481, Molecular Probes). Images were collected on a Leica TCS-SP2 confocal microscope (Leica Mycrosystems, Wetzlar, Germany) with a 63&#x000d7; Apo PLA oil immersion objective (NA 1.4) and 60 &#x003bc;m aperture. Z stacks of images were collected using a step increment of 0.2 &#x003bc;m between planes. In each panel, a single plane confocal image shows the center of a transfected cell (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Bioinformatic analysis of the <italic>IBTK</italic> genomic locus</title><p>The <italic>IBTK</italic> locus was mapped at the 6q14.1 cytogenetic location (<xref ref-type="bibr" rid="B21">21</xref>). We took advantage of the annotated sequence of chromosome 6 (<xref ref-type="bibr" rid="B40">40</xref>) to compare the cDNA coding for <italic>IBTK</italic> with the putative gene present in region 6q14.1. This region reports a gene, termed <italic>IBTK</italic> according to the sequence accession number AL050333, which spans over a 77.576 kb genomic region and includes 29 putative exons (<xref ref-type="fig" rid="F1">Figure 1</xref>A), with a predicted fully spliced mRNA of 5798 nucleotides (<xref ref-type="fig" rid="F1">Figure 1</xref>B) with an ORF coding for a protein of 1353 amino acids with a MW of 150.53 kDa (<xref ref-type="fig" rid="F1">Figure 1</xref>E; the amino acid sequence is shown in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S1A</ext-link>); this genomic sequence will be hereafter referred to as <italic>IBTK&#x003b1;</italic> (<xref ref-type="fig" rid="F1">Figure 1</xref>B). A sequence analysis of the full-length <italic>IBTK</italic> sequence revealed a putative TSS within exon 1 and a polyadenylation signal (AAUAAA) within intron 24, which would give rise to a 4437 nucleotide mRNA (<xref ref-type="fig" rid="F1">Figure 1</xref>C). This region includes an ATG translation start codon and a TAA stop codon with an ORF coding for a protein of 1196 amino acids with a MW of 133.87 kDa (<xref ref-type="fig" rid="F1">Figure 1</xref>E; the predicted amino acid sequence is shown in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S1B</ext-link>); this putative transcript will be hereafter referred to as <italic>IBTK&#x003b2;</italic> (<xref ref-type="fig" rid="F1">Figure 1</xref>C). <fig id="F1" position="float"><label>Figure 1.</label><caption><p>Schematic representation of the predicted <italic>IBTK</italic> mRNA and IBtk protein isoforms. (<bold>A</bold>) Schematic representation of the <italic>IBTK</italic> gene. The black bars depict the 29 exons of the gene. The numbers indicate the gene coordinates. (<bold>B&#x02013;D</bold>) Representation of the predicted <italic>IBTK</italic> transcripts; the exons that contribute to the distinct transcripts are indicated as bold bars. Parenthetical number indicates the transcript length. The predicted ORFs of the distinct IBtk isoforms are indicated by the start and stop codons. <bold>(E)</bold> Schematic representation of the predicted IBtk protein isoforms (&#x003b1;, &#x003b2; and &#x003b3;). Amino acid regions highlighted in blue (IBtk&#x003b2;) or in red (IBtk&#x003b3;) represent regions coded for the predicted additional exon located within intron 24.</p></caption><graphic xlink:href="gkn413f1"/></fig></p><p>The previously reported <italic>IBTK</italic> cDNA (<xref ref-type="bibr" rid="B21">21</xref>) (accession number: AF235049) is 2328-bp long and includes an ORF coding for a protein of 240 aa with a MW of 26.31 kDa. This cDNA shows a perfect match with fully spliced exons 25&#x02013;29 of the <italic>IBTK</italic> gene and includes an additional nucleotide sequence located within intron 24 of the <italic>IBTK&#x003b1;</italic> sequence (<xref ref-type="fig" rid="F1">Figure 1</xref>D), which codes for 31 amino acids of the amino terminus of the protein, hereafter referred to as Ibtk<italic>&#x003b3;</italic> (<xref ref-type="fig" rid="F1">Figure 1</xref>E; the amino acid sequence is reported in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S1C</ext-link>).</p></sec><sec><title>Analysis of <italic>IBTK</italic> transcripts</title><p>According to bioinformatics analysis, northern blot of total RNA from HeLa, Jurkat and MC3 cells using specific probes was consistent with the occurrence of three distinct spliced RNAs leading to <italic>IBTK</italic> transcripts of about 6.0, 4.5 and 2.2 kb (<xref ref-type="fig" rid="F2">Figure 2</xref>A). <fig id="F2" position="float"><label>Figure 2.</label><caption><p>Analysis of <italic>IBTK</italic> transcripts. (<bold>A</bold>) Northern blot analysis of the distinct <italic>IBTK</italic> mRNAs in HeLa, Jurkat and MC3 cells as follows: (i) <italic>IBTK&#x003b1;</italic>, 5798 nt; (ii) <italic>IBTK&#x003b2;</italic>, 4437 nt and (iii) <italic>IBTK&#x003b3;</italic>, 2328 nt. (<bold>B</bold>) Schematic representation of the <italic>IBTK</italic> genomic region covering exons 24 and 25. The region of intron 24 reports the +1 nucleotide of <italic>IBTK&#x003b3;</italic> transcript and the polyadenylation signal of <italic>IBTK&#x003b2;</italic> transcript. (<bold>C</bold>) The splicing of intron 24 was assessed by RT&#x02013;PCR analysis and nucleotide sequencing of the region of exons 24 and 25. The bold bar shows the length of the PCR product. (<bold>D</bold>) Schematic representation of the <italic>IBTK&#x003b2;</italic> transcript that includes exon 24 and intron 24, as assessed by RT&#x02013;PCR analysis of the <italic>IBTK</italic> region. The bold bar shows the length of the PCR product. The polyadenylation site identified within intron 24 is shown. (<bold>E</bold>) The <italic>IBTK&#x003b3;</italic> transcript was identified by using specific primers as shown. The bold bar shows the length of the PCR product. The picture also includes the +1 nucleotide TSS as identified by 5&#x02032; RACE. (<bold>F</bold>) RT&#x02013;PCR products of <italic>IBTK</italic> transcripts using the primers shown in (C&#x02013;E).</p></caption><graphic xlink:href="gkn413f2"/></fig></p><p>To verify the occurrence of additional nucleotide sequences from intron 24 in <italic>IBTK</italic> transcripts, mRNA was isolated from MC3 cells followed by RT&#x02013;PCR amplification and nucleotide sequencing. Primer pairs were selected according to the predicted <italic>IBTK</italic> transcripts (reported under Materials and methods section). <xref ref-type="fig" rid="F2">Figure 2</xref>B shows a schematic representation of the region covering exons 24&#x02013;25; this region includes intron 24, which hosts a putative TSS and a polyadenylation signal. The results of the RT&#x02013;PCR analysis were as follows: (i) a fully spliced <italic>IBTK&#x003b1;</italic> RNA transcript, including the splicing of intron 24 (<xref ref-type="fig" rid="F2">Figure 2</xref>C); (ii) a second <italic>IBTK&#x003b2;</italic> transcript that originates from an RNA splicing of introns 1&#x02013;23 and is terminated at a polyadenylation signal within intron 24 of the <italic>IBTK</italic> gene sequence (<xref ref-type="fig" rid="F2">Figure 2</xref>D); (iii) a third <italic>IBTK&#x003b3;</italic> transcript that originates from a TSS located within intron 24 (<xref ref-type="fig" rid="F2">Figure 2</xref>E). The PCR-amplified transcripts are shown in <xref ref-type="fig" rid="F2">Figure 2</xref>F.</p><p>Next, we identified the TSSs of the putative <italic>IBTK</italic> transcripts by using the 5&#x02032;RACE. Both the <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic> transcripts originated from a +1 nucleotide (CTTCCTC) within exon 1, which was followed by an ATG translational start codon at nucleotide +551 (Figure S2A, left panel). In the case of the <italic>IBTK&#x003b3;</italic> transcript, the TSS (CAGACT) was identified within intron 24 (Figure S2A, left panel). The 5&#x02032;RACE products are shown in Figure S2A, right panel. Further, we performed a 3&#x02032;RACE analysis of polyA mRNA to define the 3&#x02032;-end three <italic>IBTK</italic> transcripts. The 3&#x02032;RACE followed by PCR analysis and nucleotide sequencing confirmed the presence of one polyadenylation site shared by <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b3;</italic> transcripts (Figure S2B, left panel) and a distinct polyadenylation site of the <italic>IBTK&#x003b2;</italic> transcript within intron 24 (<xref ref-type="fig" rid="F3">Figure 3</xref>B, left panel). The 3&#x02032;RACE amplicons are shown in Figure S2B, right panel. <fig id="F3" position="float"><label>Figure 3.</label><caption><p>Evolutionary analysis of IBtk. (<bold>A</bold>) The diagram shows a plot of local evolutionary rates across vertebrate IBtk proteins from <italic>H. sapiens</italic>, <italic>C. familiaris</italic>, <italic>M. musculus</italic>, <italic>G. gallus</italic>, <italic>X. tropicalis, F. rubripes</italic> and <italic>T. nigroviridis</italic>. The values plotted on the <italic>y</italic>-axis are a measure of the average number of amino acid substitutions per site for residues at the corresponding <italic>x</italic>-axis position of the protein alignment. The red circles mark the nine highest scoring ECRs detected (ECRs A to I from N- to C-terminus). (<bold>B</bold>) Schematic of known protein domains found along the IBtk sequence. ANK, ankyrin repeats; RCC1, regulator of chromosome condensation; BTB, BTB/POZ domain. (<bold>C</bold>) A list of the detected ECRs is shown, which were ranked by their evolutionary relative rates. The correspondence between ECRs and known protein domains is shown. (<bold>D</bold>) Phylogenetic analysis of IBtk proteins. The enrooted maximum parsimony tree was used as an input for ECR analysis.</p></caption><graphic xlink:href="gkn413f3"/></fig></p><p>As summarized in Figure S2C, these results confirmed the occurrence of three distinct <italic>IBTK</italic> transcripts: (i) <italic>IBTK&#x003b1;</italic> mRNA (5798 nt) that arises from splicing of the complete set of 28 introns and represents the full-length <italic>IBTK&#x003b1;</italic> mRNA (sequence submission: DQ005633); (ii) <italic>IBTK&#x003b2;</italic> mRNA (4437 nt) that is contributed by exons 1&#x02013;24 and includes an additional region of 51 amino acids located within intron 24; this transcript results from the usage of a polyadenylation signal (AAUAAA) within intron 24 (sequence submission DQ005634). In this context, intron 24 is not spliced and functions as an extension of exon 24; (iii) <italic>IBTK&#x003b3;</italic> mRNA (2328 nt) that includes a cap region within intron 24, which contributes a short exon that hosts a +1 TSS and codes for 31 amino acids of the amino terminus of IBtk&#x003b3; protein (sequence submission: DQ005635).</p></sec><sec><title>Evolutionary analysis of the <italic>IBTK</italic> gene</title><p>To investigate whether similar <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic> transcripts were present in other organisms related to humans, we performed a comparative analysis of human the <italic>IBTK</italic> intron 24 with the corresponding sequences from close and distant mammalian species. To this end, we amplified genomic DNA from chimp <italic>P. troglodytes</italic> and orang <italic>P. pygmaeus</italic> by PCR using primers flanking human <italic>IBTK</italic> intron 24 (Ex24f 5&#x02032;-GTCAGCCCTCCTGTTGTGGAT-3&#x02032; and Ex25r 5&#x02032;-TGCATTCACTGGTTTGGGGGC-3&#x02032;). The PCR products were purified from agarose gels and sequenced (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S3</ext-link>). This analysis indicated that the distinct IBtk isoforms are conserved across different organisms. Indeed, we observed a 99% similarity across the analyzed species and a predicted production of the three IBtk protein isoforms (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S3</ext-link>). Further, we searched the mouse, cow and dog genomes for <italic>IBTK</italic> orthologs in BLAST analysis at the University of California at Santa Cruz (UCSC) genome browser by using the human sequence as a probe. Each retrieved sequence was carefully compared to the human <italic>IBTK</italic> genomic sequence using pair-wise TBLAST and TBLASTX, looking for splicing donor and acceptor sites to infer the gene architecture. The results showed that each investigated species has only one gene homologous to human <italic>IBTK</italic>. All genes share a common intron/exon structure (data not shown) and are therefore putative orthologs. The comparison of human <italic>IBTK</italic> intron 24 with its orthologous sequences showed that <italic>P. pygmaeus</italic>, <italic>C. familiaris and B. taurus</italic> have translation start codons ORFs that are contiguous to the downstream exons, as is the case of the human gene, indicating that their genomes can code for IBtk&#x003b3; isoform (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S4</ext-link>). <italic>Pongo pygmaeus, C. familiaris and B. taurus</italic> also have the potential to encode an IBtk&#x003b2; isoform (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S4</ext-link>). Conversely, all the potential start codons within the mouse <italic>Ibtk</italic> intron 24 are followed by stop codons; in this setting, IBtk&#x003b3; isoform begins from an ATG codon located within exon 25 (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S4</ext-link>). In addition, the sequence analysis of mouse intron 24 showed a lack of the polyadenylation signal, suggesting that the IBtk&#x003b2; protein isoform is not expressed in mice (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S4</ext-link>) (<xref ref-type="bibr" rid="B41">41</xref>). An investigation of rat <italic>Ibtk</italic> showed an analogous sequence configuration (data not shown).</p><p>The degree of evolutionary conservation for protein-coding regions and the rates of synonymous or nonsynonymous substitutions for the four investigated mammalian species (<italic>H. sapiens</italic>, <italic>M. musculus</italic>, <italic>B. taurus</italic> and <italic>C. familiaris</italic>) were calculated, and reported as <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Supplementary Figure S5</ext-link>. Sequence comparisons among the putative <italic>IBTK</italic> coding sequences in four species (<italic>H. sapiens</italic>, <italic>M. musculus</italic>, <italic>B. taurus</italic> and <italic>C. familiaris</italic>) showed that the <italic>IBTK&#x003b1;</italic>, <italic>IBTK&#x003b2;</italic>, and <italic>IBTK&#x003b3;</italic> isoforms do not differ significantly in terms of sequence conservation or evolutionary pressure (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S5</ext-link>).</p><p>Within a protein, sequences of functional relevance are subject to evolutionary constraints that force them to evolve with a significantly lower rate than other protein sites. Therefore, assessing ECRs can help to infer important functional sites along the protein sequence (<xref ref-type="bibr" rid="B29">29</xref>). To perform an ECR analysis of IBtk&#x003b1;, we retrieved additional homologous sequences from representative vertebrates (Chicken, Xenopus, Fugu and Tetraodon) at the UCSC genome browser (<xref ref-type="fig" rid="F3">Figure 3</xref>). ECR analysis identified nine regions with strong conservation among all IBtk&#x003b1; protein (ECRs a&#x02013;i) (<xref ref-type="fig" rid="F3">Figure 3</xref>). A search of the PROSITE (<xref ref-type="bibr" rid="B42">42</xref>) and SMART (<xref ref-type="bibr" rid="B43">43</xref>) databases revealed that five ECRs fall within known protein domains: (i) Ankyrin repeats, which are short, tandemly repeated modules usually involved in protein&#x02013;protein interaction (<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>); (ii) regulator of chromosome condensation 1 (RCC1), found in proteins that exert a role in the epigenetic modulation of gene expression (<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>) and (iii) BTB/POZ, found in transcriptional regulators that control chromatin structure (<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>B and C). Conversely, no known protein domains could be assigned to some ECRs, including ECRi, which is the most constrained region of IBtk (<xref ref-type="fig" rid="F3">Figure 3</xref>A) and is shared by IBtk&#x003b1; and IBtk&#x003b1; isoforms. Of interest, the ECRi corresponds to the IBtk&#x003b3; region that binds to the PH domain of Btk (<xref ref-type="bibr" rid="B21">21</xref>), suggesting that the ECRi region may function as an evolutionary conserved domain that mediates the physical interactions of IBtk with proteins that carry a PH domain.</p></sec><sec><title>Identification and functional characterization of <italic>IBTK</italic> regulatory regions</title><p>Next, we undertook a physical and functional analysis of the unknown regulatory regions of the distinct <italic>IBTK</italic> transcripts. To this end, the genomic region spanning from &#x02013;754 to +22 bp of the <italic>IBTK&#x003b1;</italic>/<italic>&#x003b2;</italic> genes upstream of the TSS were PCR amplified and cloned 5&#x02032; to the <italic>luciferase</italic> reporter gene in the pGL3B plasmid, as previously reported (<xref ref-type="bibr" rid="B50">50</xref>). This region includes <italic>cis</italic>-regulatory sequences, including CCAAT (nucleotides &#x02212;75/&#x02212;70), SP1 (nucleotides &#x02212;87/&#x02212;81), NFAT (nucleotides &#x02212;635/&#x02212;627) and YY1 (nucleotides &#x02212;662/&#x02212;656). In parallel, 5&#x02032; deletion mutants were also generated (<xref ref-type="fig" rid="F4">Figure 4</xref>A). Upon transient expression of the <italic>luciferase</italic> reporter gene in 293T cells, we identified a minimal region of &#x02212;82 + 22 of the <italic>IBTK</italic> gene that regulates the transcription of <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic> transcripts; this region includes a CCAAT <italic>cis</italic> sequence whose deletion abrogates the expression of the <italic>luciferase</italic> reporter gene, indicating that the CCAAT box functions as a major enhancer (<xref ref-type="fig" rid="F4">Figure 4</xref>A). The nucleotide sequence 5&#x02032; to the CCAAT box includes additional <italic>cis</italic>-binding sequences for SP1, NFAT and YY1 transcriptional factors; however, these regions did not increase the basal promoter activity of the &#x02212;82/+22 region (<xref ref-type="fig" rid="F4">Figure 4</xref>A). These results point to CCAAT-binding proteins as major regulators of the <italic>IBTK&#x003b1;</italic>/<italic>&#x003b2;</italic> basal gene transcription. <fig id="F4" position="float"><label>Figure 4.</label><caption><p>Analysis of <italic>IBTK</italic> promoter regions. Analysis of the <italic>IBTK&#x003b1;</italic>/<italic>IBTK&#x003b2;</italic> promoter (<bold>A</bold>) and IBTK<italic>&#x003b3;</italic> promoter (<bold>B</bold>). Human 293T cells were transfected with the indicated <italic>luc</italic> reporter gene constructs. Numbers indicate the positions relative to the first TSS of <italic>IBTK</italic> transcripts (+1). The symbols indicate the presence of promoter regulatory elements of each promoter. The firefly luciferase activity was measured 48 h posttransfection and normalized according to the &#x003b2;-galactosidase activity of the cotransfected plasmid &#x003b2;-Gal. Firefly luciferase activity of reporter gene constructs are shown as fold increase over the pGL3 basic activity. The bars indicate the average of five independent experiments with SEM.</p></caption><graphic xlink:href="gkn413f4"/></fig></p><p>To identify the regulatory regions responsible for the transcription of <italic>IBTK&#x003b3;</italic>, a region of 691 bp corresponding to nucleotide &#x02013;691 to +5 respective to +1 TSS of <italic>IBTK&#x003b3;</italic> mRNA was PCR amplified and cloned 5&#x02032; to the <italic>luciferase</italic> gene in pGL3B plasmid. A sequence analysis of this region (PROSITE) (<xref ref-type="bibr" rid="B42">42</xref>) identified an array of potential regulatory <italic>cis</italic>-sequences, such as binding sites for C/EBP&#x003b1; (nucleotides &#x02013;5/+3; &#x02013;45/-37), SP1 (nucleotide &#x02013;210/&#x02013;200), AP1 (nucleotide &#x02013;291/&#x02013;284), C/EBP&#x003b1; (nucleotides &#x02013;416/&#x02013;406), NFAT (nucleotides &#x02013;577/&#x02013;571), IRF (nucleotides &#x02013;586/576). As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>B, a significant luciferase activity was observed in 293T cells transfected with the <italic>luciferase</italic> reporter plasmid carrying &#x02013;691 to +5 nucleotide, while the deletion from &#x02013;691 to &#x02013;156 nucleotide abrogated the expression of the <italic>luciferase</italic> reporter gene. These results indicate that the <italic>cis</italic> elements contained within the sequence &#x02013;691/&#x02013;156 were required for promoter activity.</p></sec><sec><title>Analysis of the <italic>IBTK</italic> expression in a panel of human cell lines and tissues</title><p>To assess the expression of the three distinct <italic>IBTK&#x003b1;</italic>, <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic> transcripts in distinct human cell types, RNAs from the selected cells were reverse transcribed and evaluated by primer-optimized real-time PCR (<xref ref-type="fig" rid="F5">Figure 5</xref>A). The expression of the &#x003b1;, &#x003b2; and <italic>&#x003b3; IBTK</italic> transcripts was evaluated by using cDNAs from a panel of 15 human tissues (Clontech, shown in <xref ref-type="fig" rid="F5">Figure 5</xref>B). This analysis underscored a differential expression of the three <italic>IBTK</italic> mRNA isoforms, with the general trend showing <italic>IBTK&#x003b1;</italic> as the highest expressed isoform in all the examined cells and tissues, followed by <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic> (<xref ref-type="fig" rid="F5">Figure 5</xref>A and B). <fig id="F5" position="float"><label>Figure 5.</label><caption><p>Expression of the <italic>IBTK</italic> mRNAs in human cell lines and tissues.(<bold>A</bold> and <bold>B</bold>) A quantitative expression analysis of the three different <italic>IBTK</italic> mRNAs on HeLa, DeFew, Jurkat, PBMC and a panel of 15 human tissues was performed by real-time PCR. Total RNA was isolated from the distinct cell types and retro-transcribed into cDNA; cDNAs from human tissues were obtained from Clontech. <italic>IBTK&#x003b1;</italic>, <italic>IBTK&#x003b2;</italic> and <italic>IBTK&#x003b3;</italic> mRNA were quantified by real-time PCR as described under Materials and methods section. For a comparison among <italic>IBTK</italic> isoforms, the relative expression of <italic>IBTK&#x003b1;</italic> was set equal to 1 in HeLa in the case of cell types, while the expression of liver <italic>IBTK&#x003b3;</italic> was set equal to 1 in the case of human tissues. The values are reported in a logarithmic scale as the average of three independent experiments and were corrected with a normalization factor considering primers efficiency. The SEM are reported.</p></caption><graphic xlink:href="gkn413f5"/></fig></p></sec><sec><title><italic>In vivo</italic> detection of IBtk protein isoforms</title><p><italic>In vivo</italic> detection of IBtk<italic>&#x003b1;</italic>, IBtk&#x003b2; and IBtk&#x003b3; proteins was achieved by using IBtk isoform-specific antibodies. In particular, IBtk&#x003b1; and IBtk&#x003b2; were detected in cell lysates by using the 31B antibody raised in chicken by immunization with a peptide whose amino acid sequence is divergent in <italic>G. gallus</italic> and is shared by both IBtk&#x003b1; and IBtk&#x003b2; isoforms (shown in <xref ref-type="fig" rid="F6">Figure 6</xref>A; peptide amino acid sequence is underlined in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S1</ext-link>, panels A and B). To overcome the high degree of amino acid sequence homology of the <italic>IBTK</italic> locus among several species, we developed <italic>Ibtk</italic><sup>&#x02013;/&#x02013;</sup> mice by gene targeting (C. Spatuzza <italic>et al.</italic>, manuscript in preparation), which were immunized with GST-IBtk<italic>&#x003b3;</italic> protein. As expected from the <italic>IBtk</italic> gene organization, the mouse anti-GST-IBtk&#x003b3; serum was specific for IBtk&#x003b1; and IBtk&#x003b3; proteins, while the anti-31B chicken serum recognized specifically IBtk&#x003b1; and IBtk&#x003b2; (<xref ref-type="fig" rid="F6">Figure 6</xref>A and B). The three IBtk isoforms were detected in DeFew cells (<xref ref-type="fig" rid="F6">Figure 6</xref>A and B). This analysis was extended in a panel of 293T, HeLa and lymphoid cells (DeFew, Jurkat, MC3 and NB4) (<xref ref-type="fig" rid="F6">Figure 6</xref>C). Further, the expression of IBtk proteins was detected in an array of mouse tissues (<xref ref-type="fig" rid="F6">Figure 6</xref>D); in particular, western blot analysis detected IBtk&#x003b1; and IBtk&#x003b3; selectively in liver, spleen, thymus and lung; IBtk&#x003b3; was also expressed in kidney. Both proteins were undetected in brain, cerebellum and heart. Of interest, IBtk&#x003b3; was expressed at higher levels in spleen and thymus, suggesting a major role in immune regulation (<xref ref-type="fig" rid="F6">Figure 6</xref>D). According to the nucleotide sequence of the mouse <italic>IBtk</italic> locus, the IBtk&#x003b2; isoform was undetected in the mice tissues (<xref ref-type="fig" rid="F6">Figure 6</xref>D). <fig id="F6" position="float"><label>Figure 6.</label><caption><p>Detection of IBtk&#x003b1;, IBtk&#x003b2; and IBtk&#x003b3; endogenous proteins. (<bold>A</bold>) IBtk&#x003b1; (150.53 kDa) and IBtk&#x003b2; (133.87 kDa) were detected by western blot analysis of DeFew cell extracts (150 &#x003bc;g) by using the anti 31B IgY antibody (10 &#x003bc;g/ml) raised in chickens by using the 31B peptide, which was shared by IBtk&#x003b1; and IBtk&#x003b2; isoforms. The antibody specificity was assessed by using either the competitor 31B peptide (60 nmoles/ml, lane 2), or a 31B scrambled peptide (60 nmoles/ml, lane 1) in competition experiments. Input proteins were equalized by detecting the endogeneous &#x003b3;-tubulin. (<bold>B</bold>) IBtk&#x003b1; (150.53 kDa) and IBtk&#x003b3; (26.31 kDa) were detected by western blot analysis of DeFew cell extracts (100 &#x003bc;g) by using an anti-GST-IBtk&#x003b3; serum (1:500). The antibody specificities were assessed by using GST (60 nmoles/ml, lane 2), or GST-IBtk&#x003b3; (60 nmoles/ml, lane 3) proteins in competition experiments. The preimmune serum was unreactive (lane 4). Input proteins were equalized by detecting the endogeneous &#x003b3;-tubulin. (<bold>C</bold>) Expression of IBtk isoforms. Protein extracts from 293T, HeLa and lymphoblastoid cells (DeFew, Jurkat, MC3, NB4) (50 &#x003bc;g to detect IBtk&#x003b1; and IBtk&#x003b2;; 100 &#x003bc;g to detect IBtk&#x003b3;) were tested in western blots by using the indicated antibodies. Input proteins were equalized by detecting the endogeneous &#x003b3;-tubulin. (<bold>D</bold>) Expression of IBtk&#x003b1; and Ibtk&#x003b3; in mouse tissues. Western blot analysis was performed by testing 50 &#x003bc;g of protein extracts from mouse tissues. To detect IBtk&#x003b3;, we used anti GST-IBtk&#x003b3; serum as primary antibody. IBtk&#x003b1; was detected by the anti-31B IgY. Consistent with the gene organization of mouse <italic>Ibtk</italic>, the mouse IBtk&#x003b2; isoform was not detected. ECL Plus was performed to detect human IBtk&#x003b3;.</p></caption><graphic xlink:href="gkn413f6"/></fig></p><p>To evaluate the specificity of the IBtk antibodies toward the endogenous proteins, we tested the inhibitory activity of a shRNA (clone SH2631H3, Open Biosystems) that targets specifically the <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b3;</italic> transcripts (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S6A</ext-link>). As expected, expression of the SH2631H3 shRNA in Jurkat cells resulted in a drastic reduction of IBtk&#x003b1; and IBtk&#x003b3; protein isoforms, while the IBtk&#x003b2; isoform was unaffected (shown in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S6B</ext-link>).</p></sec><sec><title>Sub-cellular localization of the IBtk isoforms</title><p>The localization of the single IBtk isoforms and their <italic>in vivo</italic> association with Btk was analyzed by confocal microscopy as reported (<xref ref-type="bibr" rid="B21">21</xref>). In these experiments, the distinct IBtk isoforms were expressed in DeFew B cells and tested for co-localization with endogeneous Btk. As shown in <xref ref-type="fig" rid="F7">Figure 7</xref>, the &#x003b1; and &#x003b3; isoforms showed a mostly cytoplasmic localization and co-localized with Btk at discrete sub-membrane and cytoplasmic regions (shown in <xref ref-type="fig" rid="F7">Figure 7</xref>, upper and lower panels), consistent with the previous evidence showing that the PH-binding domain of IBtk mediates the physical interaction with Btk (<xref ref-type="bibr" rid="B21">21</xref>). Accordingly, the IBtk&#x003b2;, which showed a nuclear localization, did not colocalize with Btk (<xref ref-type="fig" rid="F7">Figure 7</xref>, middle panels). <fig id="F7" position="float"><label>Figure 7.</label><caption><p>Intracellular localization of Btk and IBtk isoforms in DeFewB lymphoma cells. DeFew cells were transiently transfected with plasmids coding for the three isoforms of IBtk (&#x003b1;, &#x003b2; and &#x003b3;) fused to FLAG tag. Twenty-four hours later, the cells were fixed and stained with FITC-conjugated anti-FLAG Ab (Green) and anti-Btk Ab, followed by Alexa-568 secondary Ab (Red) and DAPI to detect nuclear DNA. In each panel, a single plane confocal image shows the center of a transfected cell.</p></caption><graphic xlink:href="gkn413f7"/></fig></p></sec><sec><title><italic>In vivo</italic> association of IBtk with proteins expressing the PH domain</title><p>3The amino acid sequence analysis of the three IBtk isoforms shows that the &#x003b1; and &#x003b3; isoforms share a domain that mediates a binding with the PH domain of Btk; this domain is missed in the IBtk&#x003b2; isoform (<xref ref-type="bibr" rid="B21">21</xref>); shown in <xref ref-type="fig" rid="F3">Figure 3</xref>A and S1A&#x02013;C). This evidence suggests that the &#x003b1; and &#x003b2; IBtk isoforms may bind to the PH domain of multiple proteins (<ext-link ext-link-type="uri" xlink:href="http://scop.mrc-lmb.cam.ac.uk/scop-1.69/data/scop.b.c.ib.b.b.html">http://scop.mrc-lmb.cam.ac.uk/scop-1.69/data/scop.b.c.ib.b.b.html</ext-link>). To test this possibility, a panel of antibodies specific for Btk, Itk (<xref ref-type="bibr" rid="B51">51</xref>), Akt1 (<xref ref-type="bibr" rid="B52">52</xref>) and PLC&#x003b3;1 (<xref ref-type="bibr" rid="B53">53</xref>), which harbor a PH domain, were used to immune precipitate endogenous IBtk isoforms from primary PBMCs. As reported in <xref ref-type="fig" rid="F8">Figure 8</xref>, IBtk&#x003b1; was detected by western blot by using the specific 31B antibody; in the same setting, the 31B antibody failed to detect the IBtk&#x003b2; isoform, indicating the IBtk&#x003b2; does not interact <italic>in vivo</italic> with the tested proteins (<xref ref-type="fig" rid="F8">Figure 8</xref>, upper panel). The anti-GST-IBtk&#x003b3; antibody detected the IBtk&#x003b3; association with the Btk, Itk and Akt kinases (middle panel). Moreover, IBtk&#x003b3; did not bind to PLC&#x003b3;1, while IBtk&#x003b1; showed a strong binding with Btk and a weak interaction with PLC&#x003b3;1, indicating differential binding affinities for the tested proteins. The lower panel shows the cell expression of the tested proteins, as detected by western blots of the single strips from the upper and middle panels, by using the protein-specific antibodies. <fig id="F8" position="float"><label>Figure 8.</label><caption><p>Physical interaction of IBtk with Btk, Itk, Akt and PLC&#x003b3;1. The <italic>in vivo</italic> presence of protein complexes of the distinct IBtk isoforms with Btk, Itk, Akt and PLC&#x003b3;<sub>1</sub> was assessed by sequential immunoprecipitation and western blot analysis. Primary PBMC were subjected to immune precipitation with anti-Btk, anti-Itk, anti-Akt, anti-PLC&#x003b3;<sub>1</sub> and mouse IgG<sub>1</sub> control antibody. To detect IBtk&#x003b1;, IBtk&#x003b2;, IBtk&#x003b3;, immunoprecipitates were analyzed by western blotting (WB) by using the anti-31B IgY antibody (upper panel) to detect IBtk&#x003b1; and IBtk&#x003b2;, and the anti-GST-IBtk&#x003b3; antibody to detect IBtk&#x003b3; (middle panel). The lower panel shows the expression of the tested proteins as detected by western blotting with the anti-Btk, anti-Itk, anti-Akt and anti- PLC&#x003b3;<sub>1</sub>-specific antibodies.</p></caption><graphic xlink:href="gkn413f8"/></fig></p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The role of Btk in B-cell lymphopoiesis is highlighted by the clinical outcomes of XLA patients and <italic>xid</italic> mice, which have impaired Btk kinase function (<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B54">54</xref>). In fact, XLA patients and <italic>xid</italic> mice show a defective development of pre-B cells into later B-cell stages and incomplete differentiation of B-cell precursors to pre-B cells (<xref ref-type="bibr" rid="B25">25</xref>). Patients with XLA show heterogeneity in <italic>BTK</italic> gene mutations, including deletions, insertions and substitutions (<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>). Mutations occurring in the kinase domain as well as the PH, SH3 or SH2 domains, can induce variable degrees of immunodeficiency (<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B24">24</xref>). Thus, distinct regions of Btk are critical for its function in B cells, suggesting that Btk interacts physically with multiple cellular proteins. In fact, the Btk-PH domain binds to both the Ca<sup>2+</sup>-dependent (&#x003b1;, &#x003b2;I and &#x003b2;II) and Ca<sup>2+</sup>-independent isoforms (&#x003b5; and &#x003b6;) of PKC in mouse mast cells and B cells (<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>); to IP<sub>3</sub> (<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B58">58</xref>); to &#x003b2;&#x003b3; as well as G&#x003b1;12 subunits of heterotrimeric G proteins and to BAP-135 in B cells. Both G12 and BAP-135 function as positive regulators of Btk activity and do not account for the negative regulatory mechanisms required for proper Btk function. In this setting, we have previously identified IBtk as a Btk-PHBM-binding protein that effectively downregulates the Btk tyrosine kinase activity (<xref ref-type="bibr" rid="B21">21</xref>). Indeed, IBtk&#x003b3; binds to the Btk PH domain and promotes a conformational change in Btk, leading to inefficient phosphorylation of Tyr<sup>223</sup> and reduction of Btk kinase activity by <italic>trans</italic>-inhibitory mechanisms (<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B59">59</xref>). Upon binding to Btk, IBtk&#x003b3; regulates early events in B-cell activation, such as [Ca<sup>2+</sup>]<sub>i</sub> fluxes, and ultimately regulates the gene transcription program mediated by Btk upon BCR cross-linking. IBtk could play a crucial role in the <italic>in vivo</italic> regulation of Btk-mediated B-cell function. In this regard, further study of regulators of Btk, such as IBtk, may lead to a better understanding of the clinical heterogeneity in XLA syndromes characterized by genetic mutations in the Btk-PH domain. To this end, we undertook a comprehensive analysis of the genomic organization of the human <italic>IBTK</italic> locus. Here, we provide the first detailed characterization of <italic>IBTK</italic> as follows: (i) human <italic>IBTK</italic> spans over 77.58 kb and include 29 exons that give raise to three distinct <italic>IBTK</italic> mRNAs; (ii) a fully spliced <italic>IBTK&#x003b1;</italic> mRNA of 5798 nt coding for a protein of 1353 amino acid with a predicted MW of 150.53 kDa; (iii) a second <italic>IBTK&#x003b2;</italic> mRNA of 4437 nt that ends at a polyadenylation site within intron 24. The <italic>IBTK&#x003b2;</italic> mRNA includes an ORF coding for a protein of 1196 amino acids with an expected MW of 133.87 kDa. Of interest, the mouse <italic>Ibtk</italic> ortholog does not show a polyadenylation signal within intron 24, indicating that IBtk&#x003b2; protein is not produced in mice. In this regard, a phylogenetic comparative analysis of the human <italic>IBTK</italic> locus with dog, mouse, chicken, Xenopus, Fugu and Tetradon orthologs indicates that IBtk&#x003b2; is recently evolved in the human genome, suggesting a distinct role for the IBtk&#x003b2; isoform (<xref ref-type="bibr" rid="B41">41</xref>); (iv) a third human <italic>IBTK&#x003b3;</italic> mRNA results from a TSS within the intron 24 of the <italic>IBTK</italic> gene and extends over 2328 nt with a ORF coding for a protein of 240 amino acids with an expected 26.31 kDa MW. Of interest, the mouse <italic>Ibtk</italic> ortholog utilizes an ATG TSS within exon 25, with a predicted mouse Ibtk&#x003b3; isoform of 193 amino acids with a MW of 20.95 kDa.</p><p>The three <italic>IBTK</italic> transcripts are regulated by two distinct promoter regions that utilize specific <italic>cis</italic>-regulatory sequences. Indeed, the upstream promoter region (nucleotide &#x02212;754 to +22 from the +1 TSS) regulates the expression of <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b2;</italic> transcripts by using the CCAAT box (<xref ref-type="fig" rid="F4">Figure 4</xref>A), which binds preferentially to CAAT-enhancer binding proteins that are shared by most tissues and epithelial cell types (<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>). The transcription expression of <italic>IBTK&#x003b3;</italic> is regulated by a complex array of IRF-1, NFAT (<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>), CEBP&#x003b1;, AP1 and SP1 transcription factors that binds to the cognate <italic>cis</italic> sequences located at a region spanning from nucleotides &#x02212;691 to +5 from the +1 nucleotide of the <italic>IBTK&#x003b3;</italic> (<xref ref-type="fig" rid="F4">Figure 4</xref>B). This complex promoter organization is expected to be restricted to few cell types, such as immune regulatory cells that require a fine-tuned regulation of gene transcription (<xref ref-type="bibr" rid="B62">62</xref>). Consistent with the <italic>IBTK</italic> promoter organization, the real-time PCR analysis of an array of human cell lines and tissues, underscored a differential expression of the three <italic>IBTK</italic> transcripts, with <italic>IBTK&#x003b1;</italic> transcripts showing the highest expression in most of the examined cells and tissues (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p><p>Western blot analysis detected the distinct IBtk&#x003b1;, and IBtk&#x003b3; protein isoforms in human and mice cells. According to the bioinformatics analysis and as confirmed by nucleotide sequencing, the IBtk&#x003b2; isoform was detected in human cells and undetectable in mice tissues (<xref ref-type="fig" rid="F6">Figure 6</xref>). Of interest, the IBtk&#x003b3; isoform was highly expressed in human lymphoid cells and in mouse spleen cells pointing to a major role of IBtk&#x003b3; in immune regulation; this possibility is further supported by a first analysis of <italic>Ibtk<sup>&#x02212;/&#x02212;</sup></italic> mice that show abnormal proliferation and activation and lymphoid B cells (C. Spatuzza <italic>et al.</italic>, manuscript in preparation). The specificity of the anti-IBtk antibodies was assessed by transducing Jurkat cells either with empty retroviral particles, or with retroviral particles expressing a shRNA sequence specific for the <italic>IBTK&#x003b1;</italic> and <italic>IBTK&#x003b3;</italic> transcripts. Consistent with the <italic>IBTK</italic> locus organization, a significant decrease of the &#x003b1; and &#x003b3; IBtk isoforms was observed in shRNA transduced cells; as expected, the expression of IBtk&#x003b2; protein was unaffected by the shRNA expression (shown in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Figure S6</ext-link>).</p><p>The resulting IBtk&#x003b1;, IBtk&#x003b2; and IBtk&#x003b3; protein isoforms are evolutionarily conserved across vertebrates and include ECR including (i) regulator of chromosome condensation 1 (RCC1) (<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B64">64</xref>) and BTB(POZ) domains that plays a role in chromatin organization and epigenetic regulation of gene expression (<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B65">65</xref>); (ii) and ankyrin repeats, which mediate protein&#x02013;protein interactions (<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>). In addition, the computational analysis has shown a conserved domain (aa 1286&#x02013;1320 of IBtk, aa 173&#x02013;207 of IBtk&#x003b3;) with the highest relative score located at the carboxyl terminus; this region mediates the IBtk&#x003b3; interaction with the PH domain of Btk (<xref ref-type="bibr" rid="B66">66</xref>).</p><p>To address the issue of the cell colocalization of the distinct IBtk isoforms, DeFew B lymphoma cells were transduced with plasmid expressing either the &#x003b1;, &#x003b2; or the &#x003b3; IBtk isoform as FLAG-tag proteins. Cells were stained with anti-FLAG and anti-Btk antibodies and analyzed by confocal microscopy (<xref ref-type="fig" rid="F7">Figure 7</xref>). This analysis underscored a restricted cytoplasmic localization of the IBtk&#x003b3; isoform; the IBtk&#x003b1; isoform showed a strong cytoplasmic localization and detectable levels of nuclear expression, while IBtk&#x003b2; showed a restricted nuclear localization. The merging of the IBtk and Btk stainings revealed a colocalization of IBtk&#x003b1; and IBtk&#x003b3; with Btk; consistent with the lack of a PH-binding domain, IBtk&#x003b2; was not associated with Btk. These results indicate that IBtk&#x003b1; and IBtk&#x003b2;, which harbor the RCC1 and BTB/POZ domains, have diverged for the &#x003b3; isoforms to exert distinct functions as nuclear proteins.</p><p>As PH domains are shared by several proteins involved in intracellular signal transductions (<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B68">68</xref>), IBtk isoforms may bind to additional proteins and may play a regulatory role beyond the Btk-mediated signal transduction. This possibility was tested by protein&#x02013;protein interaction experiments in primary PBMC, where the three distinct IBtk isoforms were tested for <italic>in vivo</italic> binding to Btk, Itk (<xref ref-type="bibr" rid="B51">51</xref>), Akt (<xref ref-type="bibr" rid="B52">52</xref>) and PLC&#x003b3;1 (<xref ref-type="bibr" rid="B53">53</xref>) proteins. As shown in <xref ref-type="fig" rid="F8">Figure 8</xref>, IBtk&#x003b1; and IBtk &#x003b3; isoforms showed a distinct association with the tested proteins; as expected from the amino acid sequence of IBtk&#x003b2;, which lacks the PH-binding domain (<xref ref-type="fig" rid="F3">Figures 3</xref> and S1B), no binding with the PH domain of the tested proteins was observed in the case of IBtk&#x003b2;.</p></sec><sec><title>SUPPLEMENTARY DATA</title><p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn413/DC1">Supplementary Data</ext-link> are available at NAR Online.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplementary Data]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="gkn413_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn413_1.pdf"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn413_2.pdf"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn413_3.pdf"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn413_4.pdf"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn413_5.pdf"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn413_6.pdf"/><media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="gkn413_nar-00052-w-2008-File002.doc"/></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We are grateful to Dr P. Schwartzberg, NHGRI-NIH for helping in generating the <italic>Ibtk</italic><sup>&#x02212;/&#x02212;</sup> mice, Dr N. Zambrano for the <italic>IBTK</italic> siRNA clone. We thank Dr M. Rocchi, Institute of Biomedical Biotechnologies-CNR, 70100 Bari, Italy, for providing the genomic DNA of <italic>Pongo pygmaeus</italic> and <italic>Pan troglodytes</italic>. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), MIUR-PRIN, MIUR-FIRB, ISS to G.S. Funding to pay the Open Access publication charges for this article was provided by Department of Experimental and Clinical Medicine, University of Catanzaro, Italy.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>S</given-names></name><name><surname>Rawlings</surname><given-names>DJ</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name></person-group><article-title>Role of Bruton's tyrosine kinase in immunodeficiency</article-title><source>Curr. Opin. Immunol.</source><year>1994</year><volume>6</volume><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">7946052</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>LJ</given-names></name><name><surname>Finkelstein</surname><given-names>LD</given-names></name><name><surname>Lucas</surname><given-names>JA</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name></person-group><article-title>Tec family kinases in T lymphocyte development and function</article-title><source>Annu. Rev. Immunol.</source><year>2005</year><volume>23</volume><fpage>549</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">15771581</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broussard</surname><given-names>C</given-names></name><name><surname>Fleischacker</surname><given-names>C</given-names></name><name><surname>Horai</surname><given-names>R</given-names></name><name><surname>Chetana</surname><given-names>M</given-names></name><name><surname>Venegas</surname><given-names>AM</given-names></name><name><surname>Sharp</surname><given-names>LL</given-names></name><name><surname>Hedrick</surname><given-names>SM</given-names></name><name><surname>Fowlkes</surname><given-names>BJ</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name></person-group><article-title>Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk</article-title><source>Immunity</source><year>2006</year><volume>25</volume><fpage>93</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">16860760</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>S</given-names></name><name><surname>Saffran</surname><given-names>DC</given-names></name><name><surname>Rawlings</surname><given-names>DJ</given-names></name><name><surname>Parolini</surname><given-names>O</given-names></name><name><surname>Allen</surname><given-names>RC</given-names></name><name><surname>Klisak</surname><given-names>I</given-names></name><name><surname>Sparkes</surname><given-names>RS</given-names></name><name><surname>Kubagawa</surname><given-names>H</given-names></name><name><surname>Mohandas</surname><given-names>T</given-names></name><name><surname>Quan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia</article-title><source>Cell</source><year>1993</year><volume>72</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">8425221</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindvall</surname><given-names>JM</given-names></name><name><surname>Blomberg</surname><given-names>KE</given-names></name><name><surname>Valiaho</surname><given-names>J</given-names></name><name><surname>Vargas</surname><given-names>L</given-names></name><name><surname>Heinonen</surname><given-names>JE</given-names></name><name><surname>Berglof</surname><given-names>A</given-names></name><name><surname>Mohamed</surname><given-names>AJ</given-names></name><name><surname>Nore</surname><given-names>BF</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>CI</given-names></name></person-group><article-title>Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling</article-title><source>Immunol. Rev.</source><year>2005</year><volume>203</volume><fpage>200</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">15661031</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Weers</surname><given-names>M</given-names></name><name><surname>Mensink</surname><given-names>RG</given-names></name><name><surname>Kraakman</surname><given-names>ME</given-names></name><name><surname>Schuurman</surname><given-names>RK</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name></person-group><article-title>Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice</article-title><source>Hum. Mol. Genet.</source><year>1994</year><volume>3</volume><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">8162018</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Jeong</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name></person-group><article-title>The Tec family tyrosine kinase Btk regulates RANKL-induced osteoclast maturation</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>11526</fpage><lpage>11534</lpage><pub-id pub-id-type="pmid">18281276</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>JD</given-names></name><name><surname>Sideras</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>CI</given-names></name><name><surname>Vorechovsky</surname><given-names>I</given-names></name><name><surname>Chapman</surname><given-names>V</given-names></name><name><surname>Paul</surname><given-names>WE</given-names></name></person-group><article-title>Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes</article-title><source>Science</source><year>1993</year><volume>261</volume><fpage>355</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">8332900</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uckun</surname><given-names>FM</given-names></name><name><surname>Waddick</surname><given-names>KG</given-names></name><name><surname>Mahajan</surname><given-names>S</given-names></name><name><surname>Jun</surname><given-names>X</given-names></name><name><surname>Takata</surname><given-names>M</given-names></name><name><surname>Bolen</surname><given-names>J</given-names></name><name><surname>Kurosaki</surname><given-names>T</given-names></name></person-group><article-title>BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells</article-title><source>Science</source><year>1996</year><volume>273</volume><fpage>1096</fpage><lpage>1100</lpage><pub-id pub-id-type="pmid">8688094</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scharenberg</surname><given-names>AM</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9674420</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>CL</given-names></name></person-group><article-title>Btk-dependent regulation of phosphoinositide synthesis</article-title><source>Biochem. Soc. Trans.</source><year>2004</year><volume>32</volume><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">15046600</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petro</surname><given-names>JB</given-names></name><name><surname>Rahman</surname><given-names>SM</given-names></name><name><surname>Ballard</surname><given-names>DW</given-names></name><name><surname>Khan</surname><given-names>WN</given-names></name></person-group><article-title>Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement</article-title><source>J. Exp. Med.</source><year>2000</year><volume>191</volume><fpage>1745</fpage><lpage>1754</lpage><pub-id pub-id-type="pmid">10811867</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novina</surname><given-names>CD</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Bajpai</surname><given-names>U</given-names></name><name><surname>Cheriyath</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Pillai</surname><given-names>S</given-names></name><name><surname>Wortis</surname><given-names>HH</given-names></name><name><surname>Roy</surname><given-names>AL</given-names></name></person-group><article-title>Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase</article-title><source>Mol. Cell Biol.</source><year>1999</year><volume>19</volume><fpage>5014</fpage><lpage>5024</lpage><pub-id pub-id-type="pmid">10373551</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinners</surname><given-names>NP</given-names></name><name><surname>Carlesso</surname><given-names>G</given-names></name><name><surname>Castro</surname><given-names>I</given-names></name><name><surname>Hoek</surname><given-names>KL</given-names></name><name><surname>Corn</surname><given-names>RA</given-names></name><name><surname>Woodland</surname><given-names>RT</given-names></name><name><surname>Scott</surname><given-names>ML</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Khan</surname><given-names>WN</given-names></name></person-group><article-title>Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family</article-title><source>J. Immunol.</source><year>2007</year><volume>179</volume><fpage>3872</fpage><lpage>3880</lpage><pub-id pub-id-type="pmid">17785824</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Mohamed</surname><given-names>AJ</given-names></name><name><surname>Simonson</surname><given-names>OE</given-names></name><name><surname>Vargas</surname><given-names>L</given-names></name><name><surname>Blomberg</surname><given-names>KE</given-names></name><name><surname>Bjorkstrand</surname><given-names>B</given-names></name><name><surname>Arteaga</surname><given-names>HJ</given-names></name><name><surname>Nore</surname><given-names>BF</given-names></name><name><surname>Smith</surname><given-names>CI</given-names></name></person-group><article-title>Proteasome dependent auto-regulation of Bruton's tyrosine kinase (Btk) promoter via NF-{kappa}B.</article-title><source>Blood</source><year>2008</year><volume>111</volume><fpage>4617</fpage><lpage>4626</lpage><pub-id pub-id-type="pmid">18292289</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name><name><surname>Mano</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name></person-group><article-title>Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13</article-title><source>EMBO J.</source><year>1998</year><volume>17</volume><fpage>5638</fpage><lpage>5646</lpage><pub-id pub-id-type="pmid">9755164</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kersseboom</surname><given-names>R</given-names></name><name><surname>Middendorp</surname><given-names>S</given-names></name><name><surname>Dingjan</surname><given-names>GM</given-names></name><name><surname>Dahlenborg</surname><given-names>K</given-names></name><name><surname>Reth</surname><given-names>M</given-names></name><name><surname>Jumaa</surname><given-names>H</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name></person-group><article-title>Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells</article-title><source>J. Exp. Med.</source><year>2003</year><volume>198</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">12835482</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jumaa</surname><given-names>H</given-names></name><name><surname>Bossaller</surname><given-names>L</given-names></name><name><surname>Portugal</surname><given-names>K</given-names></name><name><surname>Storch</surname><given-names>B</given-names></name><name><surname>Lotz</surname><given-names>M</given-names></name><name><surname>Flemming</surname><given-names>A</given-names></name><name><surname>Schrappe</surname><given-names>M</given-names></name><name><surname>Postila</surname><given-names>V</given-names></name><name><surname>Riikonen</surname><given-names>P</given-names></name><name><surname>Pelkonen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia</article-title><source>Nature</source><year>2003</year><volume>423</volume><fpage>452</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">12761551</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hendriks</surname><given-names>RW</given-names></name><name><surname>Kersseboom</surname><given-names>R</given-names></name></person-group><article-title>Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells</article-title><source>Semin. Immunol.</source><year>2006</year><volume>18</volume><fpage>67</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16300960</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halcomb</surname><given-names>KE</given-names></name><name><surname>Contreras</surname><given-names>CM</given-names></name><name><surname>Hinman</surname><given-names>RM</given-names></name><name><surname>Coursey</surname><given-names>TG</given-names></name><name><surname>Wright</surname><given-names>HL</given-names></name><name><surname>Satterthwaite</surname><given-names>AB</given-names></name></person-group><article-title>Btk and phospholipase C gamma 2 can function independently during B cell development</article-title><source>Eur. J. Immunol.</source><year>2007</year><volume>37</volume><fpage>1033</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">17372989</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Quinto</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Palmieri</surname><given-names>C</given-names></name><name><surname>Rabin</surname><given-names>RL</given-names></name><name><surname>Schwartz</surname><given-names>OM</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name><name><surname>Scala</surname><given-names>G</given-names></name></person-group><article-title>Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein</article-title><source>Nat. Immunol.</source><year>2001</year><volume>2</volume><fpage>939</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">11577348</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitelman</surname><given-names>F</given-names></name><name><surname>Mertens</surname><given-names>F</given-names></name><name><surname>Johansson</surname><given-names>B</given-names></name></person-group><article-title>A breakpoint map of recurrent chromosomal rearrangements in human neoplasia</article-title><source>Nat. Genet.</source><year>1997</year><volume>15</volume><fpage>417</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">9140409</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Marx</surname><given-names>A</given-names></name><name><surname>Zettl</surname><given-names>A</given-names></name><name><surname>Strobel</surname><given-names>P</given-names></name><name><surname>Muller-Hermelink</surname><given-names>HK</given-names></name><name><surname>Starostik</surname><given-names>P</given-names></name></person-group><article-title>Chromosome 6 suffers frequent and multiple aberrations in thymoma</article-title><source>Am. J. Pathol.</source><year>2002</year><volume>161</volume><fpage>1507</fpage><lpage>1513</lpage><pub-id pub-id-type="pmid">12368223</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>M</given-names></name><name><surname>Grunberger</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>H</given-names></name><name><surname>Tsing</surname><given-names>SY</given-names></name><name><surname>Shaw</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Barnett</surname><given-names>J</given-names></name><name><surname>Hill</surname><given-names>RJ</given-names></name><name><surname>Swinney</surname><given-names>DC</given-names></name><name><surname>Bradshaw</surname><given-names>JM</given-names></name></person-group><article-title>Activation mechanism and steady state kinetics of Bruton's tyrosine kinase</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>8768</fpage><lpage>8776</lpage><pub-id pub-id-type="pmid">17264076</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>CM</given-names></name><name><surname>Halcomb</surname><given-names>KE</given-names></name><name><surname>Randle</surname><given-names>L</given-names></name><name><surname>Hinman</surname><given-names>RM</given-names></name><name><surname>Gutierrez</surname><given-names>T</given-names></name><name><surname>Clarke</surname><given-names>SH</given-names></name><name><surname>Satterthwaite</surname><given-names>AB</given-names></name></person-group><article-title>Btk regulates multiple stages in the development and survival of B-1 cells</article-title><source>Mol. Immunol.</source><year>2007</year><volume>44</volume><fpage>2719</fpage><lpage>2728</lpage><pub-id pub-id-type="pmid">17207856</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname><given-names>M</given-names></name><name><surname>Annunziata</surname><given-names>I</given-names></name><name><surname>Roma</surname><given-names>G</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name></person-group><article-title>Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship</article-title><source>Hum. Mol. Genet.</source><year>2005</year><volume>14</volume><fpage>3203</fpage><lpage>3217</lpage><pub-id pub-id-type="pmid">16174644</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname><given-names>M</given-names></name><name><surname>Licciulli</surname><given-names>F</given-names></name><name><surname>Catalano</surname><given-names>D</given-names></name><name><surname>Attimonelli</surname><given-names>M</given-names></name><name><surname>Caggese</surname><given-names>C</given-names></name></person-group><article-title>MitoDrome: a database of Drosophila melanogaster nuclear genes encoding proteins targeted to the mitochondrion</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>322</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">12520013</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corpet</surname><given-names>F</given-names></name></person-group><article-title>Multiple sequence alignment with hierarchical clustering</article-title><source>Nucleic Acids Res.</source><year>1988</year><volume>16</volume><fpage>10881</fpage><lpage>10890</lpage><pub-id pub-id-type="pmid">2849754</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>AL</given-names></name><name><surname>Stone</surname><given-names>EA</given-names></name><name><surname>Sidow</surname><given-names>A</given-names></name></person-group><article-title>Inference of functional regions in proteins by quantification of evolutionary constraints</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>2912</fpage><lpage>2917</lpage><pub-id pub-id-type="pmid">11880638</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galtier</surname><given-names>N</given-names></name><name><surname>Gouy</surname><given-names>M</given-names></name><name><surname>Gautier</surname><given-names>C</given-names></name></person-group><article-title>SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny</article-title><source>Comput. Appl. Biosci.</source><year>1996</year><volume>12</volume><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">9021275</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name><name><surname>Goldman</surname><given-names>N</given-names></name><name><surname>Pedersen</surname><given-names>AM</given-names></name></person-group><article-title>Codon-substitution models for heterogeneous selection pressure at amino acid sites</article-title><source>Genetics</source><year>2000</year><volume>155</volume><fpage>431</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">10790415</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korber</surname><given-names>B</given-names></name><name><surname>Muldoon</surname><given-names>M</given-names></name><name><surname>Theiler</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Lapedes</surname><given-names>A</given-names></name><name><surname>Hahn</surname><given-names>BH</given-names></name><name><surname>Wolinsky</surname><given-names>S</given-names></name><name><surname>Bhattacharya</surname><given-names>T</given-names></name></person-group><article-title>Timing the ancestor of the HIV-1 pandemic strains</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>1789</fpage><lpage>1796</lpage><pub-id pub-id-type="pmid">10846155</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burset</surname><given-names>M</given-names></name><name><surname>Seledtsov</surname><given-names>IA</given-names></name><name><surname>Solovyev</surname><given-names>VV</given-names></name></person-group><article-title>Analysis of canonical and non-canonical splice sites in mammalian genomes</article-title><source>Nucleic Acids Res.</source><year>2000</year><volume>28</volume><fpage>4364</fpage><lpage>4375</lpage><pub-id pub-id-type="pmid">11058137</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoesser</surname><given-names>G</given-names></name><name><surname>Tuli</surname><given-names>MA</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Sterk</surname><given-names>P</given-names></name></person-group><article-title>The EMBL nucleotide sequence database</article-title><source>Nucleic Acids Res.</source><year>1999</year><volume>27</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">9847133</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karolchik</surname><given-names>D</given-names></name><name><surname>Kuhn</surname><given-names>RM</given-names></name><name><surname>Baertsch</surname><given-names>R</given-names></name><name><surname>Barber</surname><given-names>GP</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Giardine</surname><given-names>B</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Hsu</surname><given-names>F</given-names></name><etal/></person-group><article-title>The UCSC Genome Browser Database: 2008 update</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>D773</fpage><lpage>D779</lpage><pub-id pub-id-type="pmid">18086701</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scala</surname><given-names>G</given-names></name><name><surname>Ruocco</surname><given-names>MR</given-names></name><name><surname>Ambrosino</surname><given-names>C</given-names></name><name><surname>Mallardo</surname><given-names>M</given-names></name><name><surname>Giordano</surname><given-names>V</given-names></name><name><surname>Baldassarre</surname><given-names>F</given-names></name><name><surname>Dragonetti</surname><given-names>E</given-names></name><name><surname>Quinto</surname><given-names>I</given-names></name><name><surname>Venuta</surname><given-names>S</given-names></name></person-group><article-title>The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein</article-title><source>J. Exp. Med.</source><year>1994</year><volume>179</volume><fpage>961</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">8113688</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">11846609</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Doherty</surname><given-names>U</given-names></name><name><surname>Swiggard</surname><given-names>WJ</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name></person-group><article-title>Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding</article-title><source>J. Virol.</source><year>2000</year><volume>74</volume><fpage>10074</fpage><lpage>10080</lpage><pub-id pub-id-type="pmid">11024136</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puca</surname><given-names>A</given-names></name><name><surname>Fiume</surname><given-names>G</given-names></name><name><surname>Palmieri</surname><given-names>C</given-names></name><name><surname>Trimboli</surname><given-names>F</given-names></name><name><surname>Olimpico</surname><given-names>F</given-names></name><name><surname>Scala</surname><given-names>G</given-names></name><name><surname>Quinto</surname><given-names>I</given-names></name></person-group><article-title>IkappaB-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>37146</fpage><lpage>37157</lpage><pub-id pub-id-type="pmid">17942396</pub-id></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Palmer</surname><given-names>SA</given-names></name><name><surname>Sims</surname><given-names>SK</given-names></name><name><surname>Edwards</surname><given-names>CA</given-names></name><name><surname>Ashurst</surname><given-names>JL</given-names></name><name><surname>Wilming</surname><given-names>L</given-names></name><name><surname>Jones</surname><given-names>MC</given-names></name><name><surname>Horton</surname><given-names>R</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Scott</surname><given-names>CE</given-names></name><etal/></person-group><article-title>The DNA sequence and analysis of human chromosome 6</article-title><source>Nature</source><year>2003</year><volume>425</volume><fpage>805</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">14574404</pub-id></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>B</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name></person-group><article-title>Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing</article-title><source>Genome Res.</source><year>2007</year><volume>17</volume><fpage>156</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">17210931</pub-id></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hulo</surname><given-names>N</given-names></name><name><surname>Sigrist</surname><given-names>CJ</given-names></name><name><surname>Le Saux</surname><given-names>V</given-names></name><name><surname>Langendijk-Genevaux</surname><given-names>PS</given-names></name><name><surname>Bordoli</surname><given-names>L</given-names></name><name><surname>Gattiker</surname><given-names>A</given-names></name><name><surname>De Castro</surname><given-names>E</given-names></name><name><surname>Bucher</surname><given-names>P</given-names></name><name><surname>Bairoch</surname><given-names>A</given-names></name></person-group><article-title>Recent improvements to the PROSITE database</article-title><source>Nucleic Acids Res.</source><year>2004</year><volume>32</volume><fpage>D134</fpage><lpage>D137</lpage><pub-id pub-id-type="pmid">14681377</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Copley</surname><given-names>RR</given-names></name><name><surname>Pils</surname><given-names>B</given-names></name><name><surname>Pinkert</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>J</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title>SMART 5: domains in the context of genomes and networks</article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>D257</fpage><lpage>D260</lpage><pub-id pub-id-type="pmid">16381859</pub-id></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>MD</given-names></name></person-group><article-title>Ankyrin repeat: a unique motif mediating protein-protein interactions</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>15168</fpage><lpage>15178</lpage><pub-id pub-id-type="pmid">17176038</pub-id></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mosavi</surname><given-names>LK</given-names></name><name><surname>Cammett</surname><given-names>TJ</given-names></name><name><surname>Desrosiers</surname><given-names>DC</given-names></name><name><surname>Peng</surname><given-names>ZY</given-names></name></person-group><article-title>The ankyrin repeat as molecular architecture for protein recognition</article-title><source>Protein Sci.</source><year>2004</year><volume>13</volume><fpage>1435</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">15152081</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>H</given-names></name><name><surname>Hurd</surname><given-names>TW</given-names></name><name><surname>Lillo</surname><given-names>C</given-names></name><name><surname>Shu</surname><given-names>X</given-names></name><name><surname>Parapuram</surname><given-names>SK</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Akimoto</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Margolis</surname><given-names>B</given-names></name><name><surname>Williams</surname><given-names>DS</given-names></name><etal/></person-group><article-title>RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>33580</fpage><lpage>33587</lpage><pub-id pub-id-type="pmid">16043481</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Parapuram</surname><given-names>SK</given-names></name><name><surname>Hurd</surname><given-names>TW</given-names></name><name><surname>Behnam</surname><given-names>B</given-names></name><name><surname>Margolis</surname><given-names>B</given-names></name><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Khanna</surname><given-names>H</given-names></name></person-group><article-title>Retinitis pigmentosa GTPase regulator (RPGR) protein isoforms in mammalian retina: insights into X-linked retinitis pigmentosa and associated ciliopathies</article-title><source>Vision Res.</source><year>2008</year><volume>48</volume><fpage>366</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">17904189</pub-id></citation></ref><ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>HK</given-names></name><name><surname>Yang</surname><given-names>HM</given-names></name><name><surname>Zhou</surname><given-names>YB</given-names></name><name><surname>Han</surname><given-names>ZG</given-names></name></person-group><article-title>ZBTB34, a novel human BTB/POZ zinc finger protein, is a potential transcriptional repressor</article-title><source>Mol. Cell Biochem.</source><year>2006</year><volume>290</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">16718364</pub-id></citation></ref><ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Dou</surname><given-names>T</given-names></name><name><surname>Ji</surname><given-names>C</given-names></name><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>K</given-names></name><etal/></person-group><article-title>Molecular cloning and characterization of a novel human BTBD8 gene containing double BTB/POZ domains</article-title><source>Int. J. Mol. Med</source><year>2004</year><volume>13</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">14654994</pub-id></citation></ref><ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ambrosino</surname><given-names>C</given-names></name><name><surname>Palmieri</surname><given-names>C</given-names></name><name><surname>Puca</surname><given-names>A</given-names></name><name><surname>Trimboli</surname><given-names>F</given-names></name><name><surname>Schiavone</surname><given-names>M</given-names></name><name><surname>Olimpico</surname><given-names>F</given-names></name><name><surname>Ruocco</surname><given-names>MR</given-names></name><name><surname>di Leva</surname><given-names>F</given-names></name><name><surname>Toriello</surname><given-names>M</given-names></name><name><surname>Quinto</surname><given-names>I</given-names></name><etal/></person-group><article-title>Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>31448</fpage><lpage>31458</lpage><pub-id pub-id-type="pmid">12055184</pub-id></citation></ref><ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Tashiro</surname><given-names>M</given-names></name><name><surname>Gibson</surname><given-names>S</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><article-title>Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on Fc epsilon RI cross-linking on mast cells</article-title><source>J. Immunol.</source><year>1995</year><volume>155</volume><fpage>3556</fpage><lpage>3562</lpage><pub-id pub-id-type="pmid">7561053</pub-id></citation></ref><ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Basson</surname><given-names>MD</given-names></name></person-group><article-title>Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion</article-title><source>Exp. Cell Res.</source><year>2008</year><volume>314</volume><fpage>286</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">17825284</pub-id></citation></ref><ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Seth</surname><given-names>A</given-names></name><name><surname>Rao</surname><given-names>R</given-names></name></person-group><article-title>Role of phospholipase Cgamma-induced activation of protein kinase Cepsilon (PKCepsilon) and PKCbetaI in epidermal growth factor-mediated protection of tight junctions from acetaldehyde in Caco-2 cell monolayers</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>3574</fpage><lpage>3583</lpage><pub-id pub-id-type="pmid">17991733</pub-id></citation></ref><ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>H</given-names></name><name><surname>Kanegane</surname><given-names>H</given-names></name><name><surname>Nomura</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Ihara</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Tsukada</surname><given-names>S</given-names></name><name><surname>Miyawaki</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name></person-group><article-title>Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>185</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">12958074</pub-id></citation></ref><ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Ozawa</surname><given-names>K</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Lehel</surname><given-names>C</given-names></name><name><surname>Fukamachi</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>WB</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><article-title>Interactions between protein kinase C and pleckstrin homology domains. Inhibition by phosphatidylinositol 4,5-bisphosphate and phorbol 12-myristate 13-acetate</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>13033</fpage><lpage>13039</lpage><pub-id pub-id-type="pmid">9148913</pub-id></citation></ref><ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venkataraman</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>XC</given-names></name><name><surname>Na</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Neote</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>SL</given-names></name></person-group><article-title>Selective role of PKCbeta enzymatic function in regulating cell survival mediated by B cell antigen receptor cross-linking</article-title><source>Immunol. Lett.</source><year>2006</year><volume>105</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">16564096</pub-id></citation></ref><ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>K</given-names></name><name><surname>Bottomley</surname><given-names>MJ</given-names></name><name><surname>Querfurth</surname><given-names>E</given-names></name><name><surname>Zvelebil</surname><given-names>MJ</given-names></name><name><surname>Gout</surname><given-names>I</given-names></name><name><surname>Scaife</surname><given-names>R</given-names></name><name><surname>Margolis</surname><given-names>RL</given-names></name><name><surname>Gigg</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>CI</given-names></name><name><surname>Driscoll</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase</article-title><source>EMBO J.</source><year>1996</year><volume>15</volume><fpage>6241</fpage><lpage>6250</lpage><pub-id pub-id-type="pmid">8947047</pub-id></citation></ref><ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Tolias</surname><given-names>KF</given-names></name><name><surname>Saci</surname><given-names>A</given-names></name><name><surname>Koon</surname><given-names>HB</given-names></name><name><surname>Humphries</surname><given-names>LA</given-names></name><name><surname>Scharenberg</surname><given-names>A</given-names></name><name><surname>Rawlings</surname><given-names>DJ</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name><name><surname>Carpenter</surname><given-names>CL</given-names></name></person-group><article-title>BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity</article-title><source>Immunity</source><year>2003</year><volume>19</volume><fpage>669</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">14614854</pub-id></citation></ref><ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>R</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><name><surname>Viney</surname><given-names>EM</given-names></name><name><surname>Murray</surname><given-names>LJ</given-names></name><name><surname>Rayner</surname><given-names>JR</given-names></name><name><surname>Jenkins</surname><given-names>BJ</given-names></name><name><surname>Gonda</surname><given-names>TJ</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name><etal/></person-group><article-title>A family of cytokine-inducible inhibitors of signalling</article-title><source>Nature</source><year>1997</year><volume>387</volume><fpage>917</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">9202125</pub-id></citation></ref><ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>M</given-names></name><name><surname>Noe</surname><given-names>V</given-names></name><name><surname>Ciudad</surname><given-names>CJ</given-names></name></person-group><article-title>Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F</article-title><source>Biochem. J.</source><year>2003</year><volume>371</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">12513689</pub-id></citation></ref><ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gronostajski</surname><given-names>RM</given-names></name></person-group><article-title>Roles of the NFI/CTF gene family in transcription and development</article-title><source>Gene</source><year>2000</year><volume>249</volume><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">10831836</pub-id></citation></ref><ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macian</surname><given-names>F</given-names></name></person-group><article-title>NFAT proteins: key regulators of T-cell development and function</article-title><source>Nat. Rev. Immunol.</source><year>2005</year><volume>5</volume><fpage>472</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">15928679</pub-id></citation></ref><ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Gorter</surname><given-names>DJ</given-names></name><name><surname>Vos</surname><given-names>JC</given-names></name><name><surname>Pals</surname><given-names>ST</given-names></name><name><surname>Spaargaren</surname><given-names>M</given-names></name></person-group><article-title>The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>1405</fpage><lpage>1414</lpage><pub-id pub-id-type="pmid">17237388</pub-id></citation></ref><ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dasso</surname><given-names>M</given-names></name></person-group><article-title>RCC1 in the cell cycle: the regulator of chromosome condensation takes on new roles</article-title><source>Trends Biochem. Sci.</source><year>1993</year><volume>18</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">8480369</pub-id></citation></ref><ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bardwell</surname><given-names>VJ</given-names></name><name><surname>Treisman</surname><given-names>R</given-names></name></person-group><article-title>The POZ domain: a conserved protein-protein interaction motif</article-title><source>Genes Dev.</source><year>1994</year><volume>8</volume><fpage>1664</fpage><lpage>1677</lpage><pub-id pub-id-type="pmid">7958847</pub-id></citation></ref><ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DiNitto</surname><given-names>JP</given-names></name><name><surname>Lambright</surname><given-names>DG</given-names></name></person-group><article-title>Membrane and juxtamembrane targeting by PH and PTB domains</article-title><source>Biochim. Biophys. Acta</source><year>2006</year><volume>1761</volume><fpage>850</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">16807090</pub-id></citation></ref><ref id="B67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><article-title>The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>9175</fpage><lpage>9179</lpage><pub-id pub-id-type="pmid">7522330</pub-id></citation></ref><ref id="B68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><article-title>Tec family protein-tyrosine kinases and pleckstrin homology domains in mast cells</article-title><source>Immunol. Lett.</source><year>1996</year><volume>54</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">9052864</pub-id></citation></ref></ref-list></back></article> 